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. 1 Purpose of the investigations 
The work reported in this thesis forms part of a research project, defined 
D study some problems related to the immune response by means of recently 
eveloped techniques of molecular biology. The major aim of this project is 
o investigate the expression of the genes for the third and fourth components 
f the complement system. 
The complement system defends man and other vertebrates against infections, 
set of at least sixteen serum proteins is involved in the activation of the 
ystem, which can be induced by antigen-antibody complexes and a variety of 
ther substances. The activation of the system comprises a cascade series of 
roteolytic cleavages and protein binding interactions, leading to the rapid 
learance of infectious agents from the inflamed site. The regulation of the 
xpression of the genes involved in the complement system is obscure. A struc-
ural analysis and study of the transcription of these genes can help to eluci-
ate these problems. In addition these studies can give an understanding of 
enetically determined deficiencies in these components. 
The development of recombinant DNA techniques recently has made it possible 
o adress these questions. Messenger RNA molecules (mRNA) can be used as template 
or reverse transcription into complementary DNA (cDNA), which can be inserted 
nto the DNA of bacterial plasmids. Bacteria are transformed with this recombi-
ant DNA and in this way pure complementary DNA can be isolated in large amounts 
rom cultures of transformed bacteria. Due to the complementarity of this DNA 
o the corresponding RNA it is refered to as cDNA-probe. DNA probes can be used 
n hybridization studies for the identification of messenger RNA and the corres-
onding gene. For instance, RNA and DNA samples can be size fractionated by gel 
lectrophoresis, followed by transfer and binding onto a solid support (eg. nitro-
ellulose filters). The position of the specific RNA or DNA bands can subsequent-
y be visualized by hybridization to a radioactive DNA probe followed by auto-
biography. In a similar way DNA probes can be used for the quantification of 
pecific RNA and DNA and for the determination of the gene copy number. The 
solation of gene fragments is monitored using DNA probes and finally the nucleo-
ide sequence of the DNA probe can be determined. 
For several reasons the genes for the complement components C3 and C4, 
are of particular interest, a) C3 is an essential component in the complement 
activation pathways and probably the most important component of the whole 
system (see 1.3.4 and the figure on page 4). b) the C4-gene(but not the C3-
gene) is located in the major histocompatibility complex (MHC, ref. 1). The 
MHC of the mouse represents the best characterized cluster of mammalian genes 
and is of great interest to immunologists, since it discriminates self from 
non-self and provides information about the genetics of biological phenomena. 
Access to the C4-gene would provide an entrance for studies of gene arrange-
ment in the MHC. c) an allogenic variant for mouse C4 exists, the Sip or 
sex-limited protein, the expression of which exhibits a strong dependence 
on testosterone (2, 3). d) feasibility reasons : C3 and C4 are the most 
abundant complement components in serum (see table 1) and have comparable 
high molecular weights; therefore their mRNAs can be identified and many steps 
in the molecular cloning can be performed for both in parallel (see 1.2 and 
chapter 3). We chose the murine complement system because the mouse is an 
animal for which many well defined inbred strains exist. This might allow 
later a comparison of differences in the DNA structure with differences in 
the genotype and phenotype. 
The work which is reported here (chapters 2,3 and 4) describes the attempt 
which were made in order to generate DNA probes complementary to C3- and C4-mRN 
and the use of the isolated DNA probe for C3 for the comparison of C3-mRNA 
levels in cells. 
1.2. Strategy 
The number of specific mRNAs from eucaryotic cells for which cDNA has 
been cloned in bacteria is increasing rapidly and the technology of molecular 
cloning has been greatly improved (4, 5, 6). This does not mean that for any 
given mRNA it is easy to identify clones which contain its corresponding cDNA. 
In the first place a specific assay must be available for the protein encoded 
by the mRNA for the identification of this mRNA. This assay must be easy and 
sensitive, especially when the abundancy of the specific mRNA is low. Only 
in few cases it is possible to purify extensively a given mRNA when this is 
only present in low amounts. Therefore the molecular cloning of a specific 
DNA usually starts with a mixture of cDNAs and the cloning procedure provides 
'or an absolute purification. However if the concentration of cDNA of interest 
s low, a high number of individual bacterial clones has to be screened for the 
iresence of this cDNA. 
Two methods are mainly used for the identification of cDNA contained in 
lacterial clones, both based on in vitro translation of mRNA which hybridizes 
pecifically to the cDNA. In the first method, the hybrid promoted translation 
7), specific mRNA is translated in vitro after it has been isolated from a 
:omplex mixture by virtue of its capacity to hybridize to the cDNA, in a way 
imilar to affinity chromatography. In the second method, the hybrid arrested 
;ranslation (8), a mixture of mRNA is translated in vitro, but a specific mRNA 
s blocked by hybridization to cDNA, thereby causing the disappearance of the 
irotein corresponding to the blocked mRNA. Many proteins are synthesized in 
:he form of a precursor which subsequently is cleaved and modified. Because the 
n vitro translation systems usually do not process the newly synthesized pro-
vins, it is important that an assay system is available that detects not only 
:he mature protein but also its possible precursors. 
For the precursors of C3 and C4, pro-C3 and pro-C4, no assays are available 
ror their functional activity, but they can be identified by immunoprecipitations 
/ith specific antisera for C3 and C4. Hybrid promoted and arrested translations 
:ollowed by immunoprecipitations are technically difficult and time consuming 
md for that reason do not allow an easy screening of a large number of cDNA 
:1ones. Since the mRNA concentrations for C3 and C4 in their major producer cells, 
:he hepatocytes, are estimated to be only 0.1-0.5% of the total mRNA (9, 10, 11), 
it was necessary to enrich for the C3- and C4-mRNA prior to the molecular cloning 
irocedure. For both C3 and C4 it has been reported that they are synthesized as 
single chain precursors of 180-200 kilodaltons and therefore their mRNAs were 
;xpected to fall into the size class of at least 5000 bases (28S). Because the 
iverage chain length mRNA in liver is 2000 bases (18S), it was anticipated that 
;he mRNAs for C3 and C4, should be separable from the bulk of the mRNA by size 
selection. The overall strategy for the cloning of DNA complementary to C3- and 
;4-mRNAs sequences was as follows : a) generation and identification of an anti-
serum against mouse C4 (chapter 2); anti mouse C3 serum is commercially avai-
lable, b) size fractionation of mRNA and identification of C3- and C4-mRNA by 
in vitro translation and immunoprecipitation (chapter 3). c) generation of 
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ouble stranded cDNA with the size selected RNA as template; insertion of it 
nto a bacterial plasmid and transformation of E.coli cells with the recombi-
ant plasmid (chapter 3) d) screening of isolated clones for the presence of 
NA inserts which are complementary to mRNA of a size corresponding with 
3- and C4-mRNA (chapter 3) and characterization of the putative C3 and C4 
lones by in vitro translation of mRNA selected by specific hybridization (7) 
ollowed by immunoprecipitation (chapter 3) 
.3 The complement system 
.3.1 The role and action of the complement system 
The complement system is a set of at least sixteen proteins in blood 
lasma and body fluids of vertebrates which plays an important role in the 
lefence mechanism against infections. The system accomplishes the clearance 
if material of both foreign origin, such as bacteria, viruses, etc., and of 
;he organism itself, eg. aged cells and cell debris, by the lysis of cells by 
lisruption of their membranes and/or phagocytosis. 
A schematic representation of the system is depicted on page 4 (for a 
letailed description see 1.3.3). The system is divided into two pathways, for 
listorical reasons called classical and alternative pathway. They represent 
;wo cascade series of proteolytic cleavages, both leading to the same important 
•esults, namely the cleavage on a large scale of C3 into C3a and C3b and the 
:leavage of C5 into C5a and C5b (for nomenclature see 1.3.2). The fragment C3b, 
ihen bound in a large number to targets, facilitates the phagocytosis of these 
:argets by white blood cells. The fragment C5b mediates the assembly of a 
»rotein complex (C5b, 6, 7, 8, 9 outer right in the figure) which can cause 
lysis of target cells by disruption of their membranes. Several small polypep-
;ides, C4a, C3a and C5a, generated by the cleavage of some of the components 
)f the complement system, are known to cause tissue inflammation (see anaphyla-
:oxins, 1.3.5). Normally this inflammation favors a fast removal of the infec-
tious agent, followed by healing. However prolonged inflammation can cause 
ierious tissue damage. 
The classical activation pathway is induced by antigen-antibody complexes. 
fhe mechanism of initiation of the alternative activation pathway is ill 
TABLE 1. THE COMPONENTS OF THE COMPLEMENT SYSTEM AND THE FRAGMENTS WHICH ARISE 
DURING THEIR ACTIVATION 
Component 
Clq 
Clr 
Cls 
C2 
C3 
C4 
C5 
C6 
C7 
C8 
C9 
B 
D 
P 
I 
H 
Fragment 
C2a 
C2b 
C3a 
C3b 
C4a 
C4b 
C5a 
C5b 
Molecular 
Weight 1) 
410'000 
83'000 
83'000 
110'000 
70'000 
30'000 
180'000 
9'000 
170'000 
200'000 
6' 000 
170'000 
180'000 
lO'OOO 
170'000 
95'000 
llO'OOO 
163'000 
70'000 
93'000 
24'000 
224'000 
88'000 
150'000 
Polypeptide 
Chains 1,2) 
A(6) 24'000 
B(6) 23'000 
C(6) 22'000 
a 120'000 
ß 70'000 
a 98'000 
ß 70'000 
Y 30'000 
a "105'000 
ß 75'000 
a 83'000 
ß 70'000 
Y lO'OOO 
(4)3)55'000 
50'000 
38'000 
Concentration in 
Serum (yg/ml) 
150 
50 
50 
15 
1200 
400 
70 
60 
55 
55 
60 
200 
1 
20 
34 
500 
l)values tor the components in human serum (14,15,16).Differences between inde-
pendant reports and various species usually do not exceed 10% of these values. 
2)determined by denaturing gel electrophoresis after reduction.The number of 
chains is indicated between brackets.The chain(s) of the fragments and compo-
nents with only one chain are not indicated.3)probably identical. 
nderstood. This pathway is stimultated by binding of C3b molecules on target 
laterial (see 1.3.3). 
.3.2 Nomenclature of the complement system 
The components of the complement system are designated here according 
:o two accepted conventions (12, 13). Two activation pathways are defined, the 
:lassical and alternative pathways, both leading to the assembly of the same 
lembrane attack complex. The classical activation pathway comprises the proteins 
:l, C2, C3 and C4; the alternative activation pathway is effected by the pro-
vins C3, B, D and P and in addition two proteins with a regulatory function, 
lamely H and I. The proteins that are involved in the membrane attack are 
lumerically designated as C5, ..., C9. Component CI is a monomolecular complex 
if the proteins Clq, Clr and Cls. The letters a, b, ..., f after the component 
lesignation, eg. C3a and C3b, refer to the fragments which result from proteo-
ytic cleavages during activation of the complement system. Greek letters, 
»g. C3a and C3ß, refer to individual polypeptide chains which arise after dena-
:uration and reduction of native components. (Enzyme) complexes of proteins are 
ndicated by the capital letter C, followed by an enumeration of the numbers 
ind symbols of the proteins, with an intervening comma, eg. C4b,2a and C3b,Bb. 
All components with their approximative molecular weights, polypeptide 
:hains and major fragments are listed in table 1. 
1.3.3 Activation of the complement system 
The activation of both the classical and alternative pathways has been 
îxtensively reviewed (14, 15, 16, 17). Here only the basic mechanism of activa-
;ion, which is schematically drawn on page 4, will be summarized. 
The classical pathway of complement activation is initiated by the presence 
)f antigen-antibody complexes of IgM and IgG type. The immune complex is 
"ecognized by CI, which binds at the second constant domain of immunoglobulins. 
31 is a complex of three components, Clq, Clr and Cls, held together by Ca 
ions. The binding of CI to immunoglobulins probably causes a conformational 
:hange in Clr, through which it becomes activated and in turn can activate Cls 
)y a proteolytic cleavage. Activated Cls is a protease and catalyses the 
hydrolysis of a serine ester bond in C4, thereby forming C4a and C4b. The 
C4b molecule posseses an active binding site for membranes, cell surfaces and 
particles. Because the active binding site has a very short half-life, the 
C4b molecule can only bind close to the site of its generation. C2 can associate 
with bound C4b, after which it can be cleaved into C2a and C2b, again by the 
activated Cls in the CI complex. The C2a in association with the C4b molecule 
can form C4b,2a which is a C3-convertase. One C3-convertase molecule (C4b,2a) 
can split several hundred molecules of C3 into the fragments C3a and C3b. Part 
of the C3b molecules bind to C4b,2a under formation of C4b,2a,3b, which is a 
C5-convertase, but the majority can adhere elsewhere to the surface of the same 
cell or particle, thus enhancing phagocytosis (see 1.3.4). 
Both the C3-and C5-convertases (C4b,2a and C4b,2a,3b) have a limited life 
span due to the fast loss of C2a which is rapidly inactivated in solution after 
its dissociation from the complex. The last proteolytic step in the pathway 
is the cleavage of C5, catalyzed by C5-convertase (C4b,2a,3b) which results in 
the formation of C5a and C5b. Finally C5b initiates an assembly process of 
itself with C6, C7, C8 and C9 (for review see 18). The complex C5b,6,7,8,9 
which is created by this self assembly process is responsible for the membrane 
attack leading to cell lysis. It is noteworthy that five different soluble pro-
teins become peripheral or possibly integral membrane constituents after this 
process of self assembly. 
The inflammation causing effect of C4a, C3a and C5a will be described 
below (1.3.5). 
The alternative activation pathway can be triggered j_n vivo and j_n vitro 
by a variety of substances, including antigen binding fragments in immune 
complexes, bacteria, protozoan parasites, animal cells, yeast cell walls and 
collagen structures of vascular basement membranes. It is thought that conti-
nuously a soluble C3-convertase is formed by the association of C3 with factor E 
in presence of factor D. The C3b molecules which are formed at a slow rate by 
this initial soluble C3-convertase can bind to many kind of particulate material 
If the bound C3b does not rapidly become inactivated (see below), factor B 
can associate with it. Subsequently factor D cleaves the bound factor B into 
Ba and Bb and C3b,Bb is formed which is a bound C3-convertase. Then the process 
becomes amplified because C3b,Bb provides for a control of the generation of 
C3b by a positive feedback. Deposition of more C3b close to C3b,Bb leads to the 
ormation of C3b,Bb,3b which is a C5-convertase and cleaves C5 into C5a and 
5b. The C5b molecules initiate in the same way as in the classical pathway the 
ormation of C5b,5,7,8,9 the membrane attack complex. 
It is postulated that the alternative pathway mainly is controlled by the 
ate of inactivation of C3b. Two proteins, factor I and H, are involved in the 
nactivation of C3b (not indicated in the figure). Factor I can cleave a peptide 
ond in the a chain of C3b which then becomes inactive. Factor H can bind to C3b 
hat impairs the binding of factor B, accelerates the dissociation of Bb from 
he C3b,Bb complex and thereby facilitates the inactivation of C3b by factor I. 
he susceptibility of C3b to factors I and H is influenced in an unknown way 
y features of the substances to which C3b is bound. There are "activating" 
ubstances which slow down the inactivation of C3b what results in the stimula-
ion of the pathway. 
In addition to the control just described, both the classical and alterna-
ive pathways are further regulated, in order to prevent large scale destruction 
n the organism. This is achieved by the cascade nature of the activation which 
Hows rapid activation but makes at the same time precise regulation possible 
y inhibition of crucial steps in the pathway. The extent of activation is 
imited by inhibition of the convertase activities and the disassembly of the 
abile convertases. Furthermore, due to the short half lives of their activated 
'inding sites, C3b and C4b can only bind close to the site of their generation. 
'his prevents non-target material to become involved in the action of the comple-
lent system. The activation of CI is controlled by CI esterase inhibitor. 
.3.4 The role of complement component C3 
Genetically determined deficiencies are known for nearly all complement 
:omponents in man and animals (for review see 19, 20, 21), but only the (almost) 
:omplete deficiency in C3 in man clearly has been related to a high susceptibi-
ity to infections (19). This is easily understood as C3 is the only essential 
:omponent in both pathways (see the figure on page 4) and C3 is a constituent 
if most of the convertases. 
The major role of the complement system probably resides in the process 
)f phagocytosis and in the generation of small polypeptides C3a, C4a and C5a 
/hich initiate tissue inflammation (see anaphylatoxins, 1.3.4). The phagocytosis 
of foreign- and self-material (bacteria, viruses, aged cells, etc.) is promoted 
by C3b. During the amplification step in the complement activation, C3-^C3a + C 
particles can become coated with C3b. This causes the immune adherence of these 
particles to C3-receptors present on a variety of cells (primate red blood cell 
non-primate platelets, lymphocytes, polymorphonuclear leucocytes, monocytes and 
macrophages), followed by ingestion and consecutive enzymatic hydrolysis by enz; 
enzymes from the granula of the white blood cells. 
The membrane attack complex mainly has been studied by the immune lysis 
of red blood cells in vitro, the socalled immune hemolysis. It is not clear to 
what extend the process of membrane attack is essential for the ornanism. 
1.3.5 Anaphylatoxins 
The polypeptides C3a, C4a and C5a, which are called anaphylatoxins, cause 
tissue inflammation (14, 17, 22). They are generated by proteolytic cleavage of 
the chains of the complement proteins. Among their effects are smooth muscle 
contraction, increase of vascular permeability, which causes a high influx of 
plasma proteins and white blood cells in the inflammed tissue. Further they 
cause the release of histamine and serotonin from mast cells upon binding to 
receptors on these cells. Prolonged inflammation can lead to serious damage of 
the tissue, eg. necrosis and the formation an an abscess. 
C5a can mediate yet another important event namely Chemotaxis (23), which 
is the directional migration of cells towards a "chemotactic" agent. C5a 
attracts polymorphonuclear leucocytes and monocytes to the site of inflammation 
It enhances the activation of a proesterase of these cells, which is thought to 
facilitate the passage of the white blood cells through the blood vessel wall. 
1.3.6. Biosynthesis of the complement components 
1.3.6.1 Producer_ce]]s_and_precursors 
The synthesis of complement components can be detected by 1) measuremenl 
of the activity of a component in a functional assay, eg. hemolytical assay; 
2) identification of newly synthesized proteins by immunological means, eg. 
immunoprecipitation after metabolic labeling of proteins. 3) detection of mRNA 
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for complement components, eg. by in vitro translation followed by immuno-
precipitation. 
It has been shown that gut-associated cells, hepatocytes and epithelial 
cells of the genito-urinary and intestinal tracts, and cells of the reticulo-
endothelial system, monocytes and macrophages, are major producers of complement 
components (for review see 24, 25, 26). It is not known whether a single cell 
is able to synthesize more than one complement component. Several types of cells 
in tissue culture produce complement components. Among these are cells of fibro-
blastoid (27, 28, 29) and hepatic origin (28, 30) as well as somatic hybrids 
between these two cell types (31). 
In their mature form several of the complement components are glycosylated 
(32, 33) and consist of multiple chains (see table 1), some of which are linked 
by disulfide bonds. Probably these separate polypeptide chains arise from a 
common precursor by posttranslational processing. For some of the complement 
components, notably C3, C4 and C5 single chain polypeptides have been detected 
by immunoprecipitation, with a size which would be expected for a single chain 
precursor (see table 2). For mouse C4 pulse chase experiments (32, 34) and for 
human C3 (35) and mouse C4 (34) tryptic peptide analysis have shown that these 
single chain molecules indeed represent precursors for the mature proteins. 
In addition, for both C3 and C4 only high molecular weight mRNAs were detected 
in mouse liver, which coded for C3 and C4 polypeptides of precursor length 
(36 chapter 3). 
1.3.6.2 Regulation of_the_biosynthesis of_the_complement_components 
The regulation of complement biosynthesis is subject to both genetic 
and non-genetic controls. The former has been extensively reviewed (19) and 
will not be discussed here. Non-genetic controls, effectuated by micro-environ-
mental facters such as hormones and inflammatory agents, form interesting model 
systems to study the molecular mechanism of regulation of gene expression. 
However such a study is complicated because a) in in vivo experiments it is 
difficult to distinguish direct action from indirect action, which may involve 
a multitude of substances; b) in vitro studies using cell lines are less complex 
but not always of biological relevance and c) the assays mentioned above 
(1.3.6.1) are also used to measure the amounts of complement components. But 
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TABLE 2. SINGLE CHAIN POLYPEPTIDES OF THE COMPLEMENT COMPONENTS C3, C4 AND C5. 
Pro-C3 
Site of Molecular
 n ,. Species
 n . .. ., . , . ,. References v
 Detection Weight 1 ) 
Mouse liver 175'000* 36 
Mouse liver 200'000* 37 
Mouse macrophage 175'000 38 
Rabbit liver 200'000* 11 
Guinea pig liver 170'000 10 
Human plasma 197'000 35, 39 
Mouse liver 190'000* 36 
Mouse macrophage 185'000 34, 40 
Mouse macrophage 200'000 32 
Pro-C4 Mouse liver 200'000 9 
Guinea pig plasma 200'000 41 
Guinea pig plasma 200'000 42 
Human plasma 200'000 
Mouse liver 170'000* 37 
Pro-C5 Mouse liver 200'000 37 
Mouse macrophage 210'000 43 
1) values obtained by gel electrophoresis under denaturing and reducing condi-
tions. The values marked by an asterisk were obtained by in vitro translation 
of mRNA. 
the level of complement activity of a complement protein, the amount of a comple-
ment protein as measured as antigen, and the level of its mRNA are not necessa-
rily similar. Therefore different methods to determine the amounts of complement 
components can lead to different results and interpretations (Chapter 4, 44, 45). 
The level of several complement components in serum, measured mainly by 
their hemolytic activity, is influenced by hormones (for review see 24, 26, 46). 
For instance in male mice the levels of some components are up to ten fold higher 
than in female mice (46). In this respect it is noteworthy that, in contrast to 
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A , the level of the inactive variant of C4, the sex limited protein or Sip (2), 
s strongly dependent on the presence of testosterone (3). The production of 
;3-activity by a well differentiated rat hepatoma cell line is reported (30) to 
ncrease up to nine fold in the presence of hydrocortisone. In contrast the same 
jlucocorticoid hormone reduced the synthesis of C2-activity in primary macro-
)hages (28). The synthetic glucocorticoid dexamethasone reduces the production of 
:3-protein in several cell lines (chapter 4). 
The serum levels of several complement components are increased, as measured 
)y activity, following generalized infection and large tissue traumas, the so-
:alled acute phase (14, 47). Infections and inflammations can be stimulated in 
laboratory animals by intra-peritoneal injections of several infectious and irri-
tating agents such as bacteria and starch (48, 49). These treatments attract many 
nacrophages to the peritoneum. For guinea pigs it has been shown that the propor-
tion of macrophages which synthesize hemolytically active C2 and C4 remains un-
altered upon injection of starch (44). For reasons mentioned above it is diffi-
cult to intrepret the results of the measurements of the amounts of newly synthe-
sized complement components in such experiments (see also the discussion in 
chapter 4). The rate of synthesis of active C2 and C4 by guinea pig macrophages 
increased (44) but for active C5 a decrease was measured (46) upon starch induc-
tion. In contrast in these experiments the synthesis of C2, C4 and C5 antigen 
did not change significantly. At present it is not clear whether these discre-
pancies reflect effects on the processing of precursor proteins into mature and 
active components and the matter can be considered to be completely open. 
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Synthesis of the mouse complement component C 4 
(Ss-protein) by peritoneal macrophages: kinetics of 
secretion and glycosylation of the subunits* 
Ss antigen was partially purified from mouse EDTA plasma, and a highly specific 
antiserum was prepared. Peritoneal exudate cells from Ss-high mouse strains were 
labeled in primary tissue culture with [35S] methionine. Ss protein was found to be 
synthesized by macrophages and to be secreted into the culture medium as shown by 
indirect immunoprecipitations performed with this antiserum. The unreduced precipi-
tated Ss molecule coelectrophoresed with human C4 at an apparent mol. wt. of 
200000. Upon reduction, Ss protein dissociated into three subunits a, ß and y of mol. 
wts. 98000, 70000 and 32000. This pattern was almost identical to the one obtained 
for human C4. The Ss a subunit was converted by human Cls into an a subunit of 
approximately 85 Kdalton. This conversion is a characteristic property of C4. A 
single-chain intracellular precursor for the Ss protein (pre-Ss: 200 Kdalton) was also 
immunoprecipitated. In pulse-chase experiments, it disappeared from the cytoplasmic 
extract within less than 10 h in a reciprocal manner to the appearance of extracellular 
mature Ss protein. No significant amounts of high-mol. wt. extracellular precursors 
were detected. A group of four single-chain molecules of mol. wt. between 160000 
and 220 000 was immunoprecipitated from the tissue culture supernatant with anti-Ss 
antiserum. These molecules could not be chased into mature Ss protein. The a, a' and 
ß subunits of Ss and the a chain of C3 incorporated [3H]mannose and 
[3H]glucosamine, the Ss y and C3 ß chains did not. 
1 Introduction 
Genes in the S region of the major histocompatibility complex 
(MHC) of the mouse control the serum levels of the Ss protein 
which is now known to be the fourth component (C4) of the 
complement system [1-4]. A variant of Ss, the Sip protein 
(sex-limited protein), is present only in the serum of males of 
certain mouse strains which carry a dominant autosomal gene 
for Sip [5]. The expression of the Sip protein is strongly depen-
dent on testosterone [6]. Sip does not mediate C4 hemolytic 
function [4], and it is not known whether it carries other func-
tions. Both the Ss and Sip polypeptides are glycosylated. Dur-
ing their secretion from producer cells they appear to be trans-
iently associated with the outer cell membrane. In this phase, 
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Abbreviations: CIG: Cold insoluble globulin DTT: Dithiothreitol PBS: 
Phosphate-buffered saline PEG: Polyethylene glycol PMSF: Phenyl 
methyl sulfonyl fluoride PEP: PBS buffer supplemented with EDTA 
and PMSF SDS: Sodium dodecyl sulfate SDS-PAGE: SDS-polyacryl-
amide gel electrophoresis TCA: Trichloroacetic acid VBS: Veronal-
buffered saline VBS++: VBS supplemented with 1 nui Mg++ and 
0.15 mM Ca++ MHC: Major histocompatibility complex 
Complement components are abbreviated according to the recom-
mendations of the Committee on Complement Nomenclature of the 
World Health Organization (Bull. WHO 1968^39.- 935). C3 and C4 
designate the third and fourth components, Cls the activated form of 
Cls. The subunits are labeled a, ß and y according to the convention, 
whereas we used a', a", a'" to designate fragments of the a chain, for 
which no official symbols have yet been proposed. 
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they may be involved in immunological mechanisms other 
than the classical complement functions [7]. For this reason, 
S-region products have recently received much attention in 
fundamental immunological research. Also, they are interest-
ing because they can be used as markers for the fine-structure 
analysis of the MHC on the genome level. Finally, the expres-
sion of the Sip protein is a particularly clear-cut example for 
control by steroid hormones in the mouse. 
Liver parenchymal cells and peritoneal macrophages have 
been demonstrated to be the principal producer cells of the 
complement components C3 and C4 in mouse and guinea pig 
[8, 9]. In particular for the mouse, in only one report [10] have 
the molecular structures of the products synthesized by mac-
rophages been studied in detail. Single-chain precursor 
molecules have been reported for both C 3 and C 4 in guinea 
pig and man [11-14]. Again, in the case of the mouse high-
mol. wt. single chain, molecules which immunologically cross-
react with the mature Ss protein have been demonstrated 
intracellularly [10], but until now the precursor-product rela-
tionship has not been carefully demonstrated by pulse-chase 
experiments and comparative peptide analysis. 
The present report describes a new procedure for the partial 
purification of Ss antigen and for the generation of a rabbit 
antiserum of high titer and specificity. Using this antiserum for 
immunoprecipitations of metabolically labeled products from 
peritoneal exudate cells in primary tissue cultures, it was con-
firmed that macrophages indeed synthesize significant 
amounts of Ss protein and secrete it into the culture medium. 
The molecular structure of the immunoprecipitated material 
was studied in detail and compared to human C4 and mouse 
C3. C3 was chosen as a specificity control throughout this 
work because it resembles C 4 in size and chemical properties. 
However, the C 3 gene has been mapped outside of the mouse 
MHC [15], and no steroid hormone control over levels of C3 
has been reported. 
0014-2980/80/0202-0075S02.50/0 
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An intracellular single-chain high-mol. wt. precursor for Ss 
was detected, and its processing into mature extracellular 
products was studied by pulse-chase experiments. Finally, 
using metabolic labeling with various radioactive sugars, the 
glycosylation of the individual subunits of Ss protein was in-
vestigated. 
2 Materials and methods 
2.1 Partial purification of Ss antigen 
Blood was collected individually from three-month-old male 
DBA/2 J mice into ice-cold 20 mM EDTA (final concentra-
tion). Plasma samples were pooled and phenyl methyl sulfonyi 
fluoride (PMSF) was added to a final concentration of 0.1 mg/ 
ml. Plasma proteins were precipitated with polyethylene glycol 
(PEG) 6000, and the 5-15% fraction was recovered essentially 
as described by Bolotin et al. [16]. The precipitate was dis-
solved in 10 mM sodium phosphate buffer, pH 7.1, containing 
0 . 1 5 M NaCl, 1% glycerol, 10 mM EDTA and 0.1 mg/ml 
PMSF. The solution was dialyzed overnight against 10 mM 
sodium acetate buffer, pH 5.3, with 5 mM EDTA and 0.1 mg/ 
ml PMSF. The precipitate was redissolved in the same sodium 
phosphate buffer as above. It was dialyzed against 50 mM 
sodium phosphate buffer, pH 8.2, containing 5 mM EDTA 
and 0.1 mg/ml PMSF and applied to QAE-Sephadex (Phar-
macia Fine Chemicals, Uppsala, Sweden) equilibrated with 
the same buffer. The column was developed with a gradient of 
sodium chloride from 0 to 0.5 M in the same buffer. In all 
purification steps, fractions positive for Ss antigen were iden-
tified by double diffusion against a reference anti-Ss antiserum 
(kind gifts from Drs. T. Meo and D. Shreffler). Positive frac-
tions were pooled, precipitated with ammonium sulfate at 
50% saturation, resuspended in phosphate-buffered saline 
(PBS) containing 10 mM EDTA, dialyzed against the same 
buffer and used for immunization. 
2.2 Purification of human C4, human Cls and mouse cold 
insoluble globulin (CIG) 
Human C4 was isolated from freshly frozen citrated plasma by 
sequential ion exchange chromatography on SP-Sephadex and 
QAE-Sephadex (R. M. Chapuis, manuscript in preparation). 
A rabbit antiserum was prepared against the purified C4 pro-
tein and the IgG fraction prepared by standard procedures. 
Reference anti-human C 4 antiserum was purchased from Nor-
dic Labs., Tilburg, NL. Human Cls was purified as described 
elsewhere [17], omitting the precautions to prevent activation 
of CI . Mouse CIG was purified using published procedures 
[18], and an antiserum against CIG was obtained from rabbits. 
2.3 Preparation of anti-mouse Ss antiserum 
Rabbits were immunized by subcutaneous injections at mul-
tiple sites with approximately 600 (ig of partially purified 
material in complete Freund's adjuvant. After three weeks, 
the animals were boosted 2-3 x at weekly intervals with 
approximately 200 \ig of the same material in incomplete 
Freund's adjuvant. For the absorption of the serum, the 15% 
PEG precipitable fractions from EDTA plasma of C3H and 
CBA/CaJax females (both H-2k, Ss low) were combined in 
equal portions and coupled covalently to Sepharose 4B using 
the cyanogen bromide procedure [19], The IgG fraction of the 
absorbed serum was then used for large-scale preparative 
immunodiffusions. The precipitin lines which corresponded to 
those obtained with reference serum were cut out from the 
agar, washed exhaustively with PEP buffer (PBS containing 
10 mM EDTA and 0.1 mg/ml PMSF) plus 0.5 \i NaCl and sub-
sequently with PEP buffer alone. They were homogenized in a 
1: 1 mixture of the same buffer with complete Freund's adjuv-
ant and used for immunization of a second series of rabbits. 
The amount of precipitated protein which each animal 
received per injection was estimated to be 25-50 ug. The final 
serum was again absorbed with Ss-low plasma and the IgG 
fraction prepared as above: it detected the Ss antigen in 
EDTA plasma of two Ss-high mouse strains (C57BL/6 males 
and DBA/2J males). No precipitin lines were observed with 
plasma from two Ss-low strains (CBA/Ca females and C311 
females). In immunodiffusion tests, the antiserum gave rise to 
a line of complete identity with the reference anti-Ss antiserum 
(Fig. 1). 
2.4 Primary tissue cultures of peritoneal cells and metabolic 
labeling 
Adult males from Ss-high strains (C57BL/6. DBA/2J) were 
killed by cervical dislocation and injected twice intraperitone-
ally with 5 ml of ice-cold Eagle's medium containing UY4 fetal 
bovine serum, L.-glutamine at 0.22 mg/ml and lacking 
methionine, if metabolic labeling was to be performed with 
radioactive methionine. If radioactive sugars were to be used, 
complete medium was taken. Peritoneal cells were transferred 
into an ice-cold centrifuge tube, sedimented. resuspended in 
0.4 ml of prewarmed medium and immediately plated out into 
plastic tissue culture petri dishes of 6 cm diameter. Each dish 
received the cells from four mice, corresponding approxi-
mately to 4 X 106 macrophages. The cells were incubated at 
37°C with 100-500 uCi of labeled precursors per plate. The 
spec. act. were approximately 100 Ci/mmol (=3.7TBq) for 
[35S] methionine and 10, respectively 19 Ci/mmol, for mannose 
II2501.ll la) 
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Figure 1. Characterization of anti-Ss antisera by double diffusion. 
(a) Demonstration of the effect of absorption. Center well: EDTA 
plasma from C57BL/6 males; (1) reference anti-Ss antiserum (Meo); 
(2) unabsorbed anti-Ss antiserum (Lausanne); (3) anti-Ss antiserum, 
same as in (2), but absorbed with pooled plasma proteins from C3H 
and CBA/Ca females; (4) same as (3), IgG fraction. 
(b) Reaction of absorbed anti-Ss antiserum with plasma from various 
mouse strains. Center well: absorbed anti-Ss antiserum (Lausanne). 
Periphery: EDTA plasma from (1) C57BL/6 males; (2) DBA/2J 
males; (3) C3H females; (4) CBA/Ca females. Note: very low 
amounts of Ss are also detected in plasma of Ss-low strains. 
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id glucosamine. When it was attempted to distinguish 
:tween synthesis by adherent cells and nonadherent cells, 
tachment was first allowed to proceed for 1 to 2 h, then the 
lis were washed twice, and only then fresh medium and label 
sre added. Cytoplasmic extracts were prepared by incubat-
g the adherent cells on the petri dish for 15 min on ice with 
5 ml of PEP buffer containing 0.5% Nonidet-P40 (NP40). 
uclei and membrane debris were removed by centrifugation 
r 5 min at 5000 rpm and the supernatant used as cytoplasmic 
:tract. 
5 Immunoprecipitations 
issue culture supernatants were concentrated approximately 
refold by dialysis against PEP buffer containing 15% PEG. 
tie samples were first cleared from material which sticks 
^specifically to Staphylococcus aureus by exhaustive 
eincubation with Staph. A (formaldehyde-fixed bacteria, 
rain Cowan I), [20]. Sequential precipitations were then car-
5d out with anti-CIG, anti-C3 and anti-Ss antisera. After 
ich incubation, the complexes were precipitated with 
aph. A. Rabbit anti-rat C3 was purchased from Nordic 
abs. and found to cross-react strongly with mouse C3. Com-
exes were washed 4 x with 1 ml each of PEP buffer contain-
g 0.5% NP40 (twice), PEP plus 0.05% NP40 (once) and 
lally PEP buffer alone. The immune complexes were eluted 
/ice with 50 u] of SDS (sodium dodecyl sulfate) sample buf-
r [21] without reducing agents by boiling for 3 min and cen-
ifugation. 
6 Analysis of immunoprecipitates by SDS Polyacrylamide gel 
electrophoresis (PAGE) 
he SDS-PAGE slab gel system was used as described by 
ämmli [21] with only half the amounts of bisacrylamide in the 
acking gels. Samples were reduced with 25 ITIM dithiothreitol 
}TT) and alkylated with a 2.2-fold molar excess of 
idoacetamide in SDS sample buffer. 
Results 
, 1 Synthesis of the Ss protein by peritoneal cells 
1.1 Adherent v.v. nonadherent cells 
ftien the total population of peritoneal exudate cells was 
laced into culture and labeled immediately with 
[35S] methionine, Ss protein was clearly synthesized and se-
creted into the tissue culture medium (Fig. 2b). When adhe-
rent cells were allowed to attach first for 2 h and nonadherent 
cells were washed away, immunoprecipitable material with a 
similar electrophoretic pattern of bands was synthesized (data 
not shown). Thus, in agreement with others [10], we con-
cluded that adherent peritoneal cells (macrophages) were cap-
able immediately after seeding into tissue culture of synthesiz-
ing Ss protein and did not need the continuous presence of 
other cells or factors secreted by other cells. However, the 
absolute amounts of immunoprecipitable, radioactively 
labeled protein was severalfold lower when cells were allowed 
to attach first. We have not observed synthesis of Ss protein 
from macrophages when labeling was performed after five 
days of culture. At this time, the attached cells still continued 
to synthesize and secrete detectable amounts of C3. We con-
clude that attached macrophages within a few days in tissue 
culture strongly reduce the level of newly synthesized and se-
creted Ss. A similar observation has been made by Roos et al. 
[10]. In addition, we were unable to detect synthesis of Ss 
protein from starch-stimulated macrophages, although these 
continued to synthesize significant amounts of C3. For these 
reasons, all data shown below were obtained using unstimu-
lated total peritoneal cell populations, labeled immediately 
after establishment of the tissue culture. 
3.1.2 Subunit structure of the extracellular Ss molecule 
In most experiments, the Ss material which was immuno-
precipitated from tissue culture supernatants gave rise after 
reduction and alkylation to three predominant bands upon 
SDS-PAGE (Fig. 2b). These have apparent mol. wts. of 
98000, 70000 and 32000. The number of three subunits and 
their apparent mol. wts. correspond well to the values 
reported by Roos et al. [10]. We therefore identified these 
bands as Ss (a), Ss (ß) and Ss (y). This identification was 
supported by several additional findings: these subunits com-
pared well to those of human C4 (see below), the same bands 
in identical relative amounts were precipitated with anti-
human C4 antiserum (Fig. 2d), but not with anti-CIG anti-
serum nor with anti-C3 antiserum (Fig. 2e, f). In addition to 
these major bands, we regularly observed minor bands (see 
Sect. 3.1.3) which have not been described in the report by 
Roos et al. [10]. The autoradiograph shown in Fig. 2b was 
scanned in a recording spectrophotometer. A semiquantitative 
evaluation was possible because it was exposed as a fluorogra-
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Figure 2. Subunit structure of reduced immuno-
precipitated Ss molecules. Electrophoresis in 15% 
SDS-polyacrylamide gels. 
(a) Mobility markers; Phosphorylase A (PA. 94 
Kdalton), catalase (CA. 60 Kdalton), and chymo-
trypsinogen (CT, 25.5 Kdalton). (b, c) Two inde-
pendent experiments with anti-Ss antiserum. The 
numbers of bands are explained in Table 1. 
(d) Precipitation with anti-human C4 antiserum 
from same macrophage culture supernatant as (c). 
(e, f) Sequential precipitates with anti-CIG (e) and 
anti-C3 (f) from same source extract as (c). Precipi-
tations (e) and (f) were performed prior to precipi-
tation (c). 
Track 2 h is a fluorography exposed on preflashed 
Kodak RP Royal X-Omat film (22]. The intensity of 
the preflash was adjusted such that the response 
curve of the film was linear between 0.15 and 2.2 
bsorbance units at 540 nm. The peak intensities of bands a. ß and y fell into the linear range so that a quantitative evaluation was possible from 
scan of this autoradiography. 
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Molecular weights of immunoprecipitated components 
Band 
1 
2 
3 
4 
5 
6 
7 
g 
9 
10 
11 
Identification 
CIG" 
Ss-relatedb> 
molecules 
(?) 
Ssa 
Ssa' 
Ssß 
Ss a" (?) 
Ss a" (?) 
Ssy 
Mol. wt. (x 10-3) 
230 
175 
170 
160 
150 
98 
85 
70 
55 
40 
32 
a) Band 1 is identified as CIG by specific immunoprecipitation with 
anti-CIG (Fig. 2e) and bv comigration with purified CIG marker 
protein. 
b) Bands 2-5 are the high-mol. wt. single-chain components which 
are described in the text; they are believed to be antigenically 
related to Ss. 
c) Bands 9 and 10 are tentatively designated breakdown fragments of 
Ss-a. because they appeared only when a' was seen and because 
human C 4 a, but not ß and ~; subunits. are specifically cleaved into 
similar-sized fragments [4]. 
phy on preflashed film ([22], see legend to Fig. 2). The a , ß 
and y bands accounted for 21 , 21 and 19 .8%, respectively, of 
the total immunoprecipi tated radioactivity. The y component 
was seen in several but not all experiments as a doublet . 
3.1.3 Minor immunoprecipitated components 
Some of the minor components which were specifically pre-
cipitated with our anti-Ss antiserum were found reproducibly, 
others in varying amounts in different experiments . We num-
bered them from the top to the bot tom of the electrophoretic 
pat tern in Fig. 2c (Table 1). The group of bands 2, 3, 4 and 5 
(discussed in Sect. 3.3.3) comprised together 18.2% of the 
total immunoprecipi tated radioactivity. 
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3.2 Comparison of mouse Ss and human C 4 proteins 
3.2.1 Size of the unreduced and reduced molecules 
Additional proof that the immunoprecipitated Ss protein is 
mouse C 4 was provided by comparison of its molecular struc-
ture with that of radioiodinated [23]. purified human C 4 . It 
has previously been shown by others that the number of sub-
units is the same and that their sizes are very similar for mouse 
and human C 4 , and that these two cross-react immunologi-
cally [3, 10]. Macrophage tissue culture supernatants were 
fractionated on an LKB Ultrogel AcA 22 column in the pres-
ence of 1.15 M NaCl prior to immunoprecipitat ion in order to 
avoid trapping of unreduced immunoprecipitated material on 
top of the gel. The Ss-containing fractions were pooled and 
concentrated by dialysis against P E P buffer containing 15% 
P E G . Sequential immunoprecipi tat ions with ant i -CIG, anti-
C 3 and anti-Ss antisera were performed, and the precipitates 
were analyzed under reducing (Fig. 3 a) and nonreducing 
(Fig. 3 b ) conditions by S D S - P A G E on 15% and 7.5% gels, 
respectively. The precipitation with ant i-CIG was performed 
in order to generate more specific immunoprecipitat ion pat-
terns, because pilot experiments had shown that our anti-Ss 
antiserum contained even after absorption significant amounts 
of contaminating ant i-CIG antibodies. The mol. wt. of the 
unreduced Ss protein coincided exactly with that of unreduced 
human C 4 (Fig. 3 b , tracks 1 and 4) and was clearly different 
from unreduced CIG (Fig. 3 b , track 2 marked by arrow) and 
unreduced C 3 (Fig. 3 b , track 3, arrow). In addition, the 
material precipitated with anti-Ss contained a component of an 
apparent mol. wt. comparable to C 3 (Fig. 3 b . track 4). This is 
probably contaminating C 3 which was not completely 
removed in the preceding immunoprecipitation step. In the 
reduced pat tern (Fig. 3 a, track 3) one clearly detects contami-
nation by C 3 subunits. The unreduced C 4 molecule migrated 
approximately as the reduced intracellular Ss precursor 
molecule (Fig. 3 b , tracks 4 and 5). Upon reduction and alky-
lation, human C 4 dissociated into three major bands: u 
(94 Kdal ton) , ß (72 Kdalton) and y (30 Kdalton) (Fig. 3 a , 
track 5), which migrated with very similar mobilities as Ss ( a ) , 
Ss (ß) and Ss (y) (Fig. 3 a. tracks 3 and 4) and appeared to be 
quite different from the a and ß subunits of C 3 (Fig. 3 a, 
track 2). 
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Figure 3. Comparison of unreduced 
(b) and reduced (a) Ss and pre-Ss 
with human C 4. Macrophage culture 
supernatants fractionated on Ul-
trogel AcA 22 column. Ss-positive 
fractions pooled and sequentially im-
munoprecipitated. Precipitates 
analyzed by SDS-PAGE in (a) 15% 
gels (reduced samples) and (b) 7.5% 
gels (unreduced samples). 
(a) (1-3) Precipitates with anti-CIG. 
anti-C3 and anti-Ss. respectively; (4) 
precipitate with anti-Ss from unfrac-
tionated macrophage culture super-
natants; (5) human C4. purified and 
radioiodinated with 12SI. 
(b) (1) human C4; (2-4) precipitates 
with anti-CIG. anti-C3 and anti-Ss, 
respectively; (5) reduced precipitate 
with anti-Ss from a cytoplasmic ex-
tract of adherent macrophages in tis-
sue culture, showing pre-Ss. 
20 
Lir. J. Immunol. 198(1. 10: 75-82 Synthesis by macrophages, secretion and glycosylation of mouse Ss-protein 
2.2 Susceptibility of Ss (a) to human Cls 
ne of the eharacteristic properties of the mouse Ss protein, 
y which it can be distinguished even from the closely related 
p protein, is that its a subunit can be specifically cleaved by 
aman Cls [4]. In order to further confirm the identity of the 
i material precipitated by our antiserum, we have treated 
3oled Ss-positive fractions from macrophage tissue culture 
ipernatants purified on Ultrogel AcA 22 columns (as above) 
ith Cls. We were able to demonstrate the generation of Ss 
i') from Ss (a) by the action of Cls (Fig. 4, tracks 3 and 4). 
he result confirmed our belief that the precipitated material 
as mouse C4 because the action of Cls is highly specific for 
4 a. Indeed, the treatment in our experiment did not affect 
ie subunits of C3. 
.3 Ss precursor molecules 
supernatants, the adherent cells were washed, and cytoplasmic 
extracts were prepared. Aliquots of tissue culture supernatants 
and cytoplasmic extracts were removed for precipitation with 
trichloroacetic acid (TCA). Then, sequential immunoprecipi-
tations were performed on all samples, and aliquots were 
taken again to determine the proportion of immunoprecipi-
table material. The kinetics of appearance of total newly syn-
thesized radiolabeled protein in the tissue culture supernatant 
is given in Fig. 5 a. The total exported acid-precipitable 
radioactive protein reached a constant concentration after 4 h 
of chase. The increase of immunoprecipitable material with 
anti-Ss antiserum in the tissue culture supernatant is shown in 
Fig. 5 b, expressed as percentage of the total extracellular 
acid-precipitable material. At most 5% of the newly syn-
thesized and secreted proteins are reacting with anti-Ss anti-
serum. As shown in Fig. 2 b, at least 60% of the reactive mate-
rial are Ss molecules. This plateau level is in very close agree-
ment with the value given by Roos et al. [10]. 
,3.1 Kinetics of appearance of Ss in tissue culture 
supernatants 
i an attempt to identify precursors and to demonstrate pre-
jrsor-product relationships we have performed pulse-chase 
speriments. Unstimulated total peritoneal exudate cells were 
ibeled immediately after establishment of tissue cultures for 
h with [^S] methionine. The tissue culture supernatants at 
ie end of this pulse labeling were recovered and stored. The 
jltures were washed and incubated in complete medium for 
arious lengths of time from 1-18 h. After harvesting of the 
SS 
* • • 
7igure 4. Action of human Cls on mouse Ss and C3. 
IDS-PAGE of reduced samples in a 15% Polyacrylamide gel. The 
Jltrogel AcA 22 column was equilibrated with VBS* ' (containing 
alcium and magnesium), and the Ss-positive fractions were concen-
ratcd by dialysis against \5('/r PEG in VBS*" * followed by brief dialy-
is against VBS ' ' without PEG. To 1 ml samples of the concentrate 
verc added either buffer (control) or 20 ng Cls. Samples were incu-
»ated 16 h at 0°C. EDTA was added to 10 mM and PMSF to 0.1 mg/ 
nl. and sequential immunoprecipitations, reduction, alkylation and 
ilectrophoresis were performed as above. 
1. 2) Precipitates with anti-C3j_(3, 4) precipitates with anti-Ss. sam-
iles treated with buffer and Cls, respectively; (5) reference precipi-
ate with anti-Ss from an unfractionated macrophage culture super-
latanl. 
•"-t 
HOURS OF CHASE 
Figure 5. Kinetics of appearance of Ss antigen in macrophage tissue 
culture supernatants. 
Primary cultures were labeled for 2 h with [35S] methionine, and 
chases were performed as described. Equal aliquots from the super-
natants after various limes of chase were precipitated with TCA or 
immunoprccipitated with anti-Ss antiserum (sequentially after anti-
CIG and anti-C3). 
(a) Total TCA-precipitable counts from tissue culture supernatants of 
adherent cells pooled from 4 mice (approximately 4 x 106 adherent 
cells) labeled with 0.1 mCi of [35S] methionine; (b) total immuno-
precipitable counts from the same source extracts as in (a) expressed 
as percentage of total TCA-precipitable protein. 
3.3.2 Intracellular precursors 
PAGE analysis of the immunoprecipitated material from the 
pulse-chase experiments is shown in Fig. 6 a for tissue culture 
supernatants and in Fig. 6 b for the corresponding cytoplasmic 
extracts. A specifically precipitated high-mol. wt. single-chain 
protein (labeled pre-Ss in Fig. 6 b) was present in the cyto-
plasm immediately after the end of the pulse (Fig. 6b, tracks 2 
and 3). Upon chases of increasing lengths, it disappeared from 
the cytoplasm (Fig. 6b, tracks 4, 5 and 6) while at the same 
time mature Ss protein accumulated in the extracellular com-
partment (Fig. 6 a. tracks 3 to 6). We therefore concluded that , 
this was the major intracellular precursor for the Ss molecule 
and named it pre-Ss. This interpretation still needs to be con-
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Figure 6. Pulse-chase experiments. 
SDS-PAGE of reduced immunoprecipitates in 15% Polyacrylamide 
gels. 
(a) Precipitates from tissue culture supernatants, tracks 1 to 6 
(Exp. 1), chase intervals of 0, 1, 2, 4, 10 and 16 h; tracks 7 and 8 
(Exp. 2), chase intervals of 0 and 19 h, respectively. 
(b) Precipitates from cytoplasmic extracts, tracks 1 to 6 (Exp. 1). 
chase intervals of 0, 1, 2, 4, 10 and 16 h; track 7 (Exp. 2). chase 
interval of 8 h; track 8 (Exp. 3), 20 h continuous labeling. 
Precipitates 1 to 6 in panels (a) and (b) were sequential precipitates 
after pre-exhaustion with anti-CIG and anti-C3; however, pre-exhaus-
tion with anti-CIG was incomplete. The position of CIG was identified 
by reference to a cold, purified CIG-marker which was included in the 
same gel. 
firmed by comparative peptide analysis. We cannot yet assign 
this molecule a reliable mol. wt., because in our experiments it 
migrates as approximately 200 Kdaltons in nonreducing, and 
as approximately 150 Kdaltons component in reducing gels. It 
corresponds in size to band 2 (Table 1) of the extracellular 
components. Mature a, a', ß and y chains were also detectable 
in low amounts in cytoplasmic extracts in some experiments 
(Fig. 6 b, tracks 1 to 3). Most of this material disappeared 
from the cytoplasm in the same time as the major precursor 
pre-Ss (Fig. 6 b, tracks 4 to 6). However, from a different type 
of experiment we concluded that no large pools of mature 
products accumulated in the cytoplasm. In this type of experi-
ment, the labeling was performed continuously for 20 h in 
order to visualize the steady-state levels of intracellular Ss-
related molecules. The result (Fig. 6b, track 8} shows that a 
significant pool of pre-Ss but no significant pools of mature 
products were present. This result demonstrates that the pres-
ence of mature a, a', ß and y chains in cytoplasmic extracts 
(Fig. 6 b, tracks 1 to 4) is overaccentuated by pulse-chase 
experiments which draw the attention to newly appearing 
material. The equilibrium concentrations óf mature compo-
nents in the cytoplasm, which are represented by continuous 
labeling experiments, are negligible with respect to the precur-
sor pre-Ss. From a third, independent experiment we have 
obtained suggestive evidence that the processing from pre-Ss 
to mature products requires living cells. In this particular 
experiment, the cells died during the labeling pulse due to the 
use of a batch of fetal calf serum different from that used in the 
other experiments, which were performed later with specially 
selected batches of serum. Upon microscopic inspection, the 
cells offered a very different morphological aspect from nor-
mal macrophages at this stage, and upon washing at the end of 
the pulse, unusually many of them detached and gave rise to 
debris in the wash liquid. Immunoprecipitations were carried 
out as in the previous experiments from cytoplasmic extracts 
and tissue culture supernatants taken immediately after the 
pulse and after increasing intervals of chase. Fig. 6 b, track 7, 
shows that intracellular precursor pre-Ss was synthesized, but 
that after 8 h of chase it was not completely delivered from the 
cytoplasm, as opposed to the corresponding situation in nor-
ma! cells (Fig. 6 b, track 5) where export after this time was 
essentially complete. Fig. 6 a. tracks 7 and 8, show the corre-
sponding analysis of the extracellular material after 0 h and 
19 h of chase. Large amounts of pre-Ss and only very minor 
amounts of mature a, ß and y chains were detected even after 
19 h of chase. In the normal situation (Fig. 6a, track 6), no 
extracellular pre-Ss was seen, but large amounts of mature 
chains. We interprète this as leakage of intracellular pre-Ss 
from dead cells into the tissue culture supernatant, where it 
was not properly processed. We suggest that processing into 
mature products requires living cells and is not likely to be 
achieved by stable pools of extracellular processing enzymes. 
There are still minor differences detectable between the pat-
terns of immunoprecipitated proteins from the supernatants of 
dead cells after 0 and 19 h of chase (Fig. 6 a, tracks 7 and 8). 
We have not investigated these in detail, but one likely expla-
nation is that, whereas proteolytic processing ceases rapidly 
upon cell death, some other form of processing (glycosylation) 
might still continue in addition to an increased leakage of cyto-
plasmic material from dead cells into the extracellular com-
partment during 19 h of chase. 
In the experiments with healthy cells, we observed that 
already after zero time and 1 h of chase (Fig. 6 a, tracks 1 and 
2), the majority of Ss-reactive extracellular material was pre-
sent as mature a, a', ß and y chains. The processing must 
therefore have occurred either very rapidly in the extracellular 
space or during the secretion from the cells. Because we failed 
in the experiment with dying cells to observe processing by 
extracellular proteases, we favor the view that processing 
takes place during the release from the cells. 
3.3.3 Extracellular Ss-related single-chain components 
High-mol. wt., single-chain polypeptides (Table 1, Bands 2, 3, 
4 and 5) have reproducibly been specifically precipitated with 
our anti-Ss antiserum. All of these together comprised 18% of 
the total immunoprecipitated radioactive protein in Fig. 2b. 
In pulse-chase experiments (Fig. 6a. tracks 1 to 6), they do 
not initially comprise the majority of radioactive material and 
do not subsequently decrease in a reciprocal way to the 
appearance of mature triple-chain Ss molecules. Therefore, it 
is unlikely that they are major extracellular precursors for 
mature Ss. These components can also be precipitated in very 
similar relative proportions with anti-human C4 antiserum 
(Fig. 2d). A similar pattern yet distinct and specific was also 
observed in several experiments for C3 (Fig. 2f). These poly-
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;ptides are probably dead-end products of aberrant proces-
ng pathways or, less likely, simple contaminants of our im-
unoprecipitations. 
4 Glycosylation of the subunits 
nstimulated peritoneal exudate cells were labeled in tissue 
ilture with [3H] mannose and [3H] glucosamine. Sequential 
imunoprecipitations from culture supernatants and subse-
uent electrophoretic analysis were then performed as above. 
s shown in Fig. 7, tracks 7 and 8, Ss (a), Ss (a'), Ss (ß) and 
>me of the high-mol. wt. single-chain Ss-related molecules 
ere labeled with both mannose and glucosamine. The Ss (y) 
ibunit did not incorporate either one of these sugars. CIG 
irried both sugars (Fig. 7, tracks 1 and 2), and so did C3a , 
hereas we failed to detect significant amounts of these sugars 
i C3ß (Fig. 7, tracks 4 and 5). Two single-chain high-mol. 
t. bands which were specifically precipitated with anti-C3 
;rum, had also incorporated these sugars (Fig. 7, tracks 4 
[id 5) . 
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7igure 7. Incorporation of mannose and glucosamine into Ss and C3. 
IDS-PAGE of reduced samples in 15% Polyacrylamide gels. 
1, 2) Precipitates with anti-CIG labeled with mannose and 
;lucosamine, respectively; (3-5) precipitates with anti-C3 labeled 
yith [3SS] methionine (3), [3H] mannose (4), [3H]glucosamine (5); 
6-8) precipitates with anti-Ss labeled with [35S] methionine (6), 
3H] mannose (7), [3H] glucosamine (8). Fluoroautoradiography with 
ireflashing and exposure on Kodak RP Royal X-Omat film was per-
ormed according to Laskey and Mills [22]. 
t Discussion 
Dne of the purposes of the present work was to produce an 
inti-Ss antiserum as a reagent for further studies on the 
expression of the Ss and Sip genes. We have described the 
production of the anti-Ss antiserum and the efforts to establish 
ts specificity. A few remarks now follow concerning the pro-
fusion of the serum. The precipitation of Ss at the isoelectric 
Doint in low salt concentration was included as a rapid initial 
Durification step. Others [24, 25] have successfully used the 
lame technique independently, and different partial purifica-
:ion procedures have been briefly described [5, 26]. It does not 
seem to be of critical importance which procedure is used to 
partially purify the antigen prior to immunization. Anti-Ss 
întisera have been obtained even by immunization with total 
mouse globulins [1]. In view of the low concentration of Ss in 
EDTA plasma (0.2% of total protein) it must be concluded 
that Ss is a highly immunogenic molecule. The specificity of an 
anti-Ss antiserum can be greatly enhanced by absorption of the 
crude antiserum with plasma proteins from Ss-low mice. It was 
of substantial advantage to pool for this purpose plasma pro-
teins from several different Ss-low mouse strains. The effi-
ciency of the absorption was increased by coupling the adsorb-
ing agents covalently to Sepharose 4B. The regeneration of 
the columns was optimized by using as desorbing agent 0.1 M 
glycine at pH 2.5. The following observations showed that the 
antiserum precipitated Ss in a highly specific manner: the 
number and size of the subunits and the size of the unreduced 
molecule matched the reported values [10]; the size of the 
precipitated molecule and its subunit composition was very 
similar to human C4 and different from mouse C3; the 
molecule was synthesized by the expected cell type and was 
susceptible to specific proteolytic attack by human Cls; the 
precipitable molecules were present in plasma from two Ss-
high mouse strains in much higher concentrations than in the 
plasma from two Ss-low strains. 
Several new facts emerged about the synthesis and secretion of 
the Ss molecule and its glycosylation: 
(a) A single-chain, high-mol. wt. precursor for Ss (pre-Ss) was 
found intracellularly, which in pulse-chase experiments 
showed the appropriate behavior for a major precursor. 
(b) A group of four extracellular high-mol. wt. proteins was 
detected of size between 150 and 220 Kdaltons, which are 
probably antigenically related to the Ss molecule. They are 
single-chain components which could not be chased into 
mature Ss protein. At least two of these were found to be 
glycosylated. A similar group of several high-mol. wt. single-
chain polypeptides was also precipitated with anti-C3 anti-
serum from macrophage culture supernatants. However, these 
proteins were distinct in their exact mol. wts. from those pre-
cipitated with anti-Ss antiserum. 
(c) Under steady-state labeling conditions, no large pools of 
mature intracellular Ss molecules were found to accumulate, 
and no large amounts of major extracellular precursors were 
detected. Thus, the processing from the single-chain precursor 
into the triple-chain mature product is likely to occur in a 
timed correlation with the secretion of the molecules from the 
producer cells. 
(d) The a, a' and ß chains of Ss and C 3 a incorporated man-
nose and glucosamine, whereas we could not detect these 
sugars incorporated into Ss y and C3ß chains. 
(e) Peritoneal macrophages in primary tissue culture ceased to 
secrete significant amounts of Ss molecules into the culture 
medium within 48 h, whereas they continued to secrete detect-
able amounts of newly synthesized C3. These observations 
confirm the original findings of Roos et al. [10]. The synthesis 
of C3 and C4 might be subject to different control mechan-
isms, because the genes for these two proteins are located in 
distant regions of chromosome 17 of the mouse [15, 27]. 
Our data suggest the existence of a major intracellular precur-
sor (pre-Ss) which under steady-state conditions was present in 
excess concentrations over mature Ss chains. This precursor 
had been previously decribed by others [10]. The new finding 
is that in chase experiments, it disappeared in good kinetic 
correlation with the appearance of extracellular mature prod-
ucts. The details of the processing scheme have still to be 
elaborated. A mechanism of cell-associated proteolytic cleav-
age is compatible with our data, but a very rapid extracellular 
cleavage could not be completely excluded. This would have 
to take place so fast that already after 1 h of chase, no 
extracellular precursor would be left. 
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The extracellular high-mol. wt. single-chain polypeptides, 
which were precipitated with anti-Ss antiserum, could not be 
chased into mature products and, therefore, are not functional 
precursors. They could be present due to aberrant processing 
at a low level. Because a similar but distinct group of 
molecules was specifically precipitated with anti-C3 anti-
serum, we favor the interpretation that these molecules are 
antigenically related to C4 and C3, respectively. The trivial 
explanation that they are due to contaminant antibodies in the 
sera has not been ruled out. So-called single-chain "precur-
sors" have also been observed at a level of less than 5% of the 
mature product in mouse EDTA plasma [10] and in human 
plasma [13, 14]. In these cases, a precursor-product relation-
ship has not been demonstrated, and therefore those 
molecules should not be called "precursors" yet. 
It appears unlikely that one of the radioactive components 
immunoprecipitated from macrophage culture supernatants is 
the C4b-binding protein described by Ferreira et al. [28]. The 
Ss protein, which was used for the first cycle of immunization, 
was partially purified from EDTA plasma. For the second 
round of immunizations, precipitin material was used which 
was again generated from EDTA plasma and should not con-
tain the C4b-binding protein. Thus, our anti-Ss antiserum is 
not likely to contain anti-C4b-binding protein antibodies. It is 
also unlikely that the C4b-binding protein should be co-
precipitated with Ss protein from the macrophage tissue cul-
ture supernatant, because the majority of the material is pre-
sent in our experiments as C4, whereas the C4b-binding pro-
tein has been shown to bind specifically to C4b [28]. All the 
immunoprecipitations were carried out in presence of EDTA 
and protease inhibitors in order to prevent the conversion 
from C4 to C4b. Finally, it is not known whether C4b-bind-
ing protein is synthesized by peritoneal macrophages in pri-
mary cultures in sufficient amounts to be visible in autoradio-
graphs of newly synthesized, secreted proteins. 
We can also exclude that one of these high-mol. wt. proteins is 
related to the Sip protein, because the macrophages used in 
this experiment were taken from C 57 BL/6 mice which are Sip-
negative. 
Mannose and glucosamine are abundant sugars in glycopro-
teins, and mannose is found as a core sugar almost universally 
[29]. The fact that we did not find these sugars in the Ss (y) 
chain makes it likely that this chain is not glycosylated. Gly-
cosylation of the y chain of human C4 has not been firmly 
established. Marginal sugar contents have been reported for it 
[30, 31] which in both reports could not be quantitated. 
Human C3 has been reported to contain between 1 and 3% of 
carbohydrates [32, 33], but the glycosylation of the subunits 
has not been studied. 
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Mouse liver mRNA species which direct the cell-free 
ynthesis of pro-C3 and pro-C4 polypeptides with an 
;pparent molecular weight of 175,000 and 190,000, re-
pectively, were shown to sediment faster than 28 S. By 
lectrophoresis in a denaturing gel the mRNA for C3 
pas determined to contain approximately 7,500 ribo-
tucleotides. cDNA was synthesized from size-fraction-
ited mouse liver mRNA and cloned in the plasmid pBR 
122. Among the cDNA clones recovered three were 
dentified as being complementary to portions of the 
nRNA for C3. 
The third and fourth components of the complement system 
C3 and C4) are serum glycoproteins, which in mammalian 
irganisms participate in defense reactions against infections 
1). C3 is an essential element in both the classical and the 
ilternative pathways of complement utilization. While partial 
23 deficiencies in humans have been reported, complete C3 
leficiencies are rarely observed, due to fatal childhood infec-
ions (2). In contrast, complete homozygous C4 deficiencies 
vithout associated serious disease have been detected in hu-
nans (3) and guinea pigs (4). Humans have two separate loci 
'or two distinct hemolytically active C4 proteins (5,6). In mice 
mly one gene is known for hemolytically active C4. Mice, 
ïowever, possess a variant of the C4 protein (Sip or sex-
imited protein), which is probably the product of a duplicated 
jene (7, 8) but which has no C4-hemolytical function (9). 
Human and mouse C4 genes are located inside the major 
listocompatibility complex (HLA, H-2), whereas the human 
33 gene is not linked to the HLA complex (10) and the mouse 
33 gene is located distant from the H-2 complex on the same 
;hromosome (11). 
C3 is synthesized as an intracellular precursor (pro-C3) of 
in approximate molecular weight of 170,000 which is proc-
essed by proteolytic cleavage into two mature chains a, 120,000 
and ß, 70,000 (12, 13). Similarly, C4 is synthesized as a single 
chain precursor (pro-C4) with an approximate molecular 
weight of 200,000. It is cleaved into a disulfide-bonded triple 
chain with subunits a (98,000), ß (70,000), and y (32,000) with 
minor species variations (14-16). 
The major site of synthesis of C3 (and probably C4) is the 
liver (17). Secondary sites are the peritoneal macrophages (15, 
* This work was supported by Grant 3.273-078 SR from the Swiss 
National Foundation for Scientific Research. The costs of publication 
of this article were defrayed in part by the payment of page charges. 
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£ Recipient of a fellowship from the Swiss Confederation and of 
the Emil Barell Foundation (Hoffmann-La Roche and Cie SA). 
§ Recipient of European Molecular Biology Organization Fellow-
ship ALTF-93-1979. 
16) and a few other cell types (18, 19). The biosynthesis of C3, 
C4, and other complement proteins can be regulated by hor-
mones (18), and in particular, the mouse Sip protein is strongly 
dependent on testosterone (7). 
Our goal is to study the structure and the arrangement of 
the genes for C3 and C4, the control of their expression, and 
their alterations in inherited disorders. As tools for these 
studies we have attempted to clone cDNA sequences of C3 
and C4. We report here: 1) the characterization of the sizes 
and cell-free translation properties of the mRNAs for C3 and 
C4, and 2) the construction and identification of recombinant 
plasmids containing sequences complementary to mRNA for 
C3. 
E X P E R I M E N T A L PROCEDURES 
Animals—Adult DBA/2J male mice were used for all experiments 
except that mRNA from C57/BL6 adult males was used for the 
synthesis of cDNA. Both mouse strains are kept as continuous stock 
in the animal facility of our institute. 
Materials—OUgo(dT)-cellulose type II was purchased from the 
Collaborative Research Inc. Anti-C3 serum (GAM-BlC) was obtained 
from Nordic, Tilburg, The Netherlands. Anti-C4 serum (anti-Ss) was 
prepared as described earlier (16). The following materials were 
generous gifts: reverse transcriptase from avian myeloblastosis virus 
of Dr. J. Beard (National Cancer Institute, Bethesda, Md.); Sl-nu-
clease of Dr. U. Schibler (Swiss Institute for Experimental Cancer 
Research, Epalinges, Switzerland); the plasmid pBR 322 and Esche-
richia coli strain K12-HB101 of Dr. W. Gehring (University of Basel, 
Switzerland); tetracycline (Achromycin) of Opopharma (Zürich). Am-
picilline (Penbritin) was obtained from Beecham Research Labora-
tories. MeHgOH (water-soluble) was purchased from Alpha, [a-
32P]ATP and [y-J2P]ATP were from the Radiochemical Centre Ltd, 
Amersham. Formamide (p.a., Merck) was recrystallized twice before 
use. Calf liver tRNA (Boehringer) and E. coli tRNA (Sigma) were 
extracted with phenol-chloroform prior to use. Pst I was prepared as 
was previously described (20). 
Containment—All work involving recombinant DNA was carried 
out according to the National Institutes of Health guidelines for 
recombinant DNA. Recombinant plasmids were constructed under 
P3 physical, and EK1, biological containment (HB101, pBR 322) 
(National Institutes of Health guidelines of April 11, 1979). 
Preparation of Partially Purified RNA—Polyadenylated RNA 
was prepared from fresh mouse livers by phenolchloroform extraction 
and oligo(dT) chromatography as described elsewhere (21) with the 
following modifications: 0.2 mg/ml of heparin was present during the 
homogenization and 0.5 mg/ml during the phenolchloroform extrac-
tions; the loading buffer for the oligo(dT)-cellulose column contained 
0.3 M NaCl. 
An average of 60 /ig of polyadenylated RNA was recovered per 
liver, containing no detectable amounts of 28 S ribosomal RNA (Fig. 
2.4, position 5.1 kilobases). For size fractionation, the polyadenylated 
RNA was heated for 3 min at 68°C in 0.5% SDS,1 chilled, and loaded 
on a linear 5 to 25% (w/w) sucrose gradient (12 ml) in a buffer 
1
 The abbreviations used are: SDS, sodium dodecyl sulfate; base, 
(deoxy) ribonucleotide; DBM-paper, diazobenzyloxymethyl paper; 
MeHgOH, methylmercuryhydroxide; Pipes, 1,4-piperazinediethane-
sulfonic acid. 
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containing 0.1 M NaCl, 0.01 M Tris-HCl (pH 7.4), 0.001 M EDTA, and 
0.5% SDS. Between 0.4 and 0.6 mg of RNA were loaded on one 
gradient. After centrifugation for 4V> h at 40,000 rpm at 25°C in an 
SW 40 rotor (Beekman), the 3=28 S fraction (approximately 5% of the 
total) was collected and precipitated twice with ethanol. 
Cell-free Translation—Cell-free translations were carried out using 
a commercial rabbit reticulocyte lysate (New England Nuclear) with 
['HJleucine or [''SJmethionine as radioactive precursors. Translation 
conditions were as specified by the supplier and essentially as previ-
ously described (22). Approximately 150 ng of mRNA were used/12.5-
pl reaction. 
Immunoprecipitation—For direct immunoprecipitation, transla-
tion reactions were diluted with 0.6ml of detergent buffer, containing 
0.15 M NaCl, 0.1 M Na-phosphate (pH 7.1), 0.02 M EDTA, 0.1% SDS, 
1% Na-deoxycholate, 1% Nonidet P-40, and 0.1 mg/ml of phenyl-
methylsulfonyl fluoride. Fresh EDTA-plasma was prepared as de-
scribed earlier (16). It was added as a source of carrier protein to 
immunoprecipitation reactions at equivalence with the antiserum: 5 
j j of EDTA-plasma plus 150 ill of anti-C3 serum or 25 pi of EDTA-
plasma plus 150 fil of anti-C4 serum. Precipitations were allowed to 
proceed overnight at 4°C. The immunoprecipitate was collected by 
centrifugation through a cushion of 1 M sucrose in detergent buffer 
for 10 min at 16,000 x g, washed once with detergent buffer, and twice 
with 0.15 M NaCl and 0.1 M Na-phosphate (pH 7.1). 
SDS-Polyacrylamide Gel Electrophoresis—Discontinuous 7.5% 
gels and electrophoresis buffer were prepared according to an estab-
lished procedure (23). Samples were boiled for 5 min in 5% SDS, 0.08 
M Tris-HCl (pH 6.8), 9% glycerol, 0.002% bromphenol blue, and 5% 
dithiothreitol. After the electrophoresis the gels were treated with 
50% (w/v) trichloroacetic acid, stained and destained. Fluorography 
was performed with En'Hance (New England Nuclear). Radioactive 
bands were visualized on a preflashed film (24). 
Molecular Cloning ofcDNA—Double stranded cDNA was synthe-
sized as described elsewhere (25). Twenty-five micrograms of size 
fractionated mRNA (^28 S) was incubated in a 0.5-ml reaction 
mixture with 50 units of reverse transcriptase for the synthesis of the 
first strand and with 100 units for the synthesis of the second strand. 
Approximately 2 [ig of Sl-nuclease-resistant DNA were recovered 
and size-fractionated by centrifugation in a sucrose gradient. Fractions 
containing DNA of approximately 2000 to 2500 and 2500 to 6000 
basepairs were pooled and precipitated twice with ethanol. Homo-
polymeric extensions were added to the cDNA using terminal trans-
ferase (Bethesda Research Laboratories, Inc.) as described elsewhere 
(26). cDNA (0.2 fig) was incubated in a 200-jd reaction with 10 units 
of terminal transferase at 37°C for 10 s, in order to reach a tail length 
of 8 to 30 (dC) per 3'-end. After phenolchloroform extraction, the 
material was precipitated twice with ethanol. pBR 322 DNA was 
digested with Pst I, linear molecules were selected and elongated with 
(dG)ni tails. Equimolar amounts of vector and cDNA (200 ng in total) 
were annealed in 0.6 ml of 0.1 M NaCl, 10 mM Tris-HCl (pH 7.5), and 
0.2 mM EDTA." E. coli cells (strain K12-HB101) were transformed 
with 200 ng of this DNA mixture as described previously (27). 310 
ampicUline-sensitive and tetracycline-resistant colonies were isolated. 
Colony hybridizations were carried out as described elsewhere (28) 
using gel eluted RNA as probe. Gel-eluted RNA (see below) was 
dissolved in 0.1 M NaOH and incubated for 30 min on ice, neutralized, 
and precipitated with ethanol. End-labeling was performed with [y-
;,2P]ATP using T4-polynucleotide kinase (P-L Biochemicals, Ref. 29). 
Candidate clones were grown on a preparative scale, plasmids were 
amplified with chloramphenicol (0.2 mg/ml), and DNA was prepared 
by the cleared lysate procedure followed by banding in a CsCl gradient 
containing ethidiumbromide as previously described (30). 
Gel Electrophoresis and Gel Elution of RNA—mRNA was size-
fractionated by electrophoresis in 1% agarose gels containing 5 mM 
MeHgOH as described previously (31). For elution of RNA, 250 fig of 
polyadenylated RNA were loaded on a preparative slot (50 x 4 X 1 
mmJ). Electrophoresis proceeded for 40 h at 1.5 V/cm. Side strips 
were stained with ethidium bromide and RNA bands were localized 
by photography under UV light. RNA bands were excised from the 
preparative gel according to the stained pattern. RNA was recovered 
from the gel slices as described elsewhere (21) except that 0.5 M LiCl 
was replaced by 0.5 M ammonium acetate in order to fix the MeHgOH. 
For analytical hybridizations RNA was separated in the same way, 
using 50 t^g of RNA in a slot of 5-cm width. After electrophoresis, the 
RNA was transferred onto DBM-paper as previously described (32) 
2
 According to Rowekamp and Firtel, personal communication. 
except that the transfer medium was buffered with 25 mM K-phos-
phate (pH 6.5). 
Gel Electrophoresis and Gel Elution of DNA—DNA restriction 
fragments were separated by electrophoresis in horizontal 1% agarose 
gels in 40 mM Tris-HCl, pH 7.8, 5 mM Na-acetate, and 1 mM EDTA. 
For hybridization purposes the DNA was transferred onto nitro-
cellulose sheets as described elsewhere (33). Preparative elution of 
DNA fragments from agarose was performed as described previously.'' 
Hybridizations—RNA, which was immobilized on DBM-paper 
(Northern blot) was hybridized with nick-translated (34) recombinant 
DNA probes as described elsewhere (32). 
Plasmids, carrying cDNA inserts, were immobilized on DBM-paper 
and used for preparative hybridization with RNA, essentially as 
previously described (35). Eight sets of two filters of 11 mm in 
diameter, carrying each 10 to 20 (ig of linearized single-stranded 
plasmid DNA, were prehybridized in 4 ml of 50% (v/v) formamide, 
0.6 M NaCl, 15 mM Pipes (pH 6.4), 0.2% SDS, 100 /ig/ml of poly(U), 
and 1 mg/ml of calf liver tRNA for 30 min at 41°C. The main 
hybridization contained all filters in 0.8 ml of 50% (v/v) formamide, 
0.6 M NaCl, 1.5 mM EDTA, 0.2% SDS, 100 fig/mi of poly(U), 250 [ig/ 
ml of calf liver tRNA, and approximately 100 ^g of size fractionated 
mRNA (^28 S). After a hybridization period of 22 h at 41°C, the 
filters were washed batchwise 6 times for 10 min at 41GC with 20 ml 
of 50% (v/v) formamide, 45 mM NaCl, 4.5 mM Na-citrate, 20 mM Pipes 
(pH 6.4), 1 mM EDTA, and 0.2% SDS. Hybridized RNA was eluted 
from each set of filters by four subsequent incubations at 65°C in 100 
yl of preheated 80% (v/v) formamide, 0.1% SDS, 10 mM Pipes (pH 
6.4), and 20 ,ug/ml of E. coli tRNA, precipitated three times with 
ethanol and translated in vitro. 
Hybridization of DNA immobilized on nitrocellulose sheets was 
performed as described elsewhere (33). 
Demonstration of the Presence of the mRNAs for pro-C3 
and pro-C4 in Mouse Liver—In order to show t h a t t h e liver 
is one of the sites of synthesis of C3 and C4 in t he mouse, we 
t rans la ted total mouse liver m R N A in vitro (Fig. I A, Track 
4) and performed immunoprec ip i ta t ions on the products with 
ant ibodies specific for C3 and C4. T h e s e immunoprec ip i ta t ions 
provided indicat ions for the synthesis of C3 and C4 (data not 
shown) . Because of t he relatively low translat ional efficiency 
of high molecular weight m R N A s we fractionated t h e to ta l 
m R N A prior to t ranslat ion. Trans la t ion products specified by 
the 3*28 S fraction are shown in Fig. \At Track 5. T h e 
presence of pro-C3 and pro-C4 (Fig. M , Tracks 2 a n d 3, 
indicated by arrows) was demons t ra t ed by direct immunopre -
cipitat ions on a 10-fold larger sample , to which unlabeled C3 
and C4 (from plasma) were added at equivalence with t he 
ant isera. T h e character is t ic pa t t e rn of subuni ts of p lasma C3 
and C4 after staining the prote ins is shown in Fig. I ß , indi-
ca ted by arrows. T h e C3 a subuni t can clearly be seen (Fig. 
IB, Tracks 2 a n d 7), whereas mos t of t h e C3 ß subuni t 
disappeared, probably due to proteolytic cleavage giving rise 
to t he band C3x. T h e a, ß, and y subuni ts of C4 and Sip can 
all be seen (Fig. IB, Tracks 3 and 8). Th i s pa t t e rn of s ta ined 
immunoprec ip i ta ted prote ins served as internal control for 
t he high specificity of t he immunoprecipi ta t ion . T h e specific-
ity of t he goat ant i -mouse-C3 serum was further confirmed by 
our observat ion t h a t a rabbi t an t i - ra t -C3 serum precipi ta ted 
t he same pa t t e rn of nonradioact ive proteins from mouse 
p lasma (data not shown) . 
We de termined for pro-C3 a size of approximate ly Mr = 
175,000 and for pro-C4 of Mr = 190,000 (Fig. 1 A, Tracks 2 and 
3). Pro te ins of lower molecular weight were also specifically 
immunoprec ip i ta ted . T h e y represent probably p remature ly 
t e rmina ted polpept ides. N o produc ts of sizes similar to those 
of pro-C3 and pro-C4 were de tec ted upon t ransla t ion of frac-
t ions of R N A sediment ing slower t h a n 28 S (data not shown). 
'McMaster, G. K., 
Virology, in press. 
Beard, P., Engers, H., and Hirt, B. (1980) 
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FIG. 1. SDS-polyacrylamide gel e lect rophoresis of t rans la -
tion produc ts . A, mRNA samples were translated in vitro and their 
products were analyzed directly or after immunoprecipitation by 
SDS-polyacrylamide gel electrophoresis. Three microliters of the 
total translation products and all of the irnmunoprecipitate were 
loaded on each track. Track 1, molecular weight markers: radioactive: 
240,000 filamin, 200,000 myosin, 185,000 macroglobulin, 92,500 Phos-
phorylase B (New England Nuclear); from the stained gel: RNA 
polymerase at 165,000 and 155,000. Track 2, direct immunoprecipi-
tation with anti-C3 serum from 28 \A of the assay in Track 5. Track 
3, as Track 2, but with anti-C4 serum (exposure time 3-fold longer as 
for the other tracks). Track 4, 150 ng of unfractionated mRNA were 
translated in a 125-^1 assay. Track 5, 450 ng of size-fractionated (3*28 
S) RNA were translated in a 60-jd assay. Track 6, translation products 
of RNA which was selected by hybridization with a recombinant 
plasmid containing C3-related sequences (pMLC-3) translated in a 
60-fil assay. Track 7, direct immunoprecipitation with anti-C3 serum 
from 28 fil of the same assay as in Track 6. Track 8, as Track 7, but 
with anti-C4 serum. B, the same gel but stained with Coomassie 
brilliant blue. 
Size Determination of the mRNAs for C3 and C4—In order 
to de te rmine t he sizes of t h e m R N A s for C3 and C4, we eluted 
m R N A from slices of a dena tur ing M e H g O H agarose gel (31). 
Several discrete bands of R N A species migrat ing slower t h a n 
28 S r ibosomal R N A (5.1 kilobases) could be dist inguished on 
the original p ic ture (indicated by arrows in Fig. 2A). After 
elut ion, t h e R N A was divided into two aliquots. One was used 
for colony hybridizat ion(see below) and the o ther was t rans-
la ted in vitro (Fig. 3). Track T represents t ransla t ion products 
of unfract ionated m R N A , Tracks 1 to 6 represent t he products 
of t he R N A eluted from the Slices 1 to 6, respectively (Fig. 
2 A). Trans la t ion produc ts with t h e same appa ren t moleoular 
weight as pro-C4 (190,000) and pro-C3 (175,000), indicated by 
arrows, were mainly specified by R N A eluted from Slices 2 
(—8.4 kilobases) and 3 ( -7 .5 kilobases). Therefore , it is likely 
t h a t t he m R N A s for C3 and C4 contain approximate ly 7.5 and 
8.4 kilobases. T o o small a m o u n t s of e luted R N A were availa-
ble to perform immunoprecip i ta t ions on the cell-free transla-
t ion products , but t he size est imat ion for t he m R N A for C3 
was confirmed by hybridizat ion da ta (Fig. 2B, see below). 
Characterization of Recombinant Plasmids containing 
cDNA—We followed a general cloning procedure which has 
been previously described (36). Double-s t randed c D N A was 
inser ted into t he Pst I restriction site of t he plasmid p B R 322 
FIG. 2. Agarose gel e lect rophoresis of RNA. RNA was sepa-
rated by electrophoresis in denaturing agarose gels containing 5 mM 
MeHgOH (31). Electrophoresis was for 40 h at 1.5 V/cm. A, 250 fig of 
mRNA were loaded on a preparative gel. A side strip was stained and 
photographed (two exposures are shown). Regions indicated with 1 
to 7 were excised from the corresponding gel and the RNA was eluted 
(see text). The arrows indicate individual bands which could be 
detected on the original picture. B, 50 /ig of mRNA were loaded in a 
slot of 5-cm width and electrophoreses as under A on a parallel gel. 
The RNA was transferred to and bound on DBM-paper (32). Individ-
ual strips of the paper were hybridized with nick-translated recom-
binant plasmids. Strip 1, recombinant plasmid containing C3-related 
sequences (pMLC3-l); Strip 2, plasmid containing sequences related 
to a 165,000-dalton protein (non C3-related); Strip 3, a plasmid 
containing sequences coding for an unidentified protein. The size 
calibration of the mRNAs was achieved using ribosomal RNA and its 
precursors. Their sizes are given in kilobases: 18 S = 2.0, 28 S = 5.1, 
32 S - 6.3, 36 S = 7.7, and 41 S = 9.6 (37). 
and recombinant molecules were used to t ransform E. coli 
s t ra in HB101 . Identification of t he p lasmids was achieved in 
two steps: 1) colony hybridizat ion (28) with a specific R N A 
probe; 2) hybrid-selected t ransla t ion (35) followed by immu-
noprecipi tat ion. 
For t he colony hybridizat ion we used R N A which was 
e lu ted from slices of a gel (see above, Fig. 2A) as probe. 
Because it was clear from Fig. 3 t h a t more t h a n one a b u n d a n t 
m R N A species was p resen t in each of t h e R N A samples e lu ted 
from the Slices 2 and 3 (Fig. 2A), we performed a mult iple 
screening using several probes . T h e D N A of 20 colonies hy-
bridized significantly wi th one or more of t he R N A probes 
from Slices 2, 3, and 4 (Fig. 2A), bu t none hybridized wi th t h e 
control R N A from Slice 7 (data not shown) . Plasmid D N A s 
which hybridized only with t h e probe from Slice 3 were 
classified as candida tes for C3 and o thers hybridizing wi th 
b o t h t h e probes from t h e Slices 2 a n d 3 were classified as 
candida tes for C4. 
In order to establ ish t he coding specificity of t he cand ida te 
plasmids, dena tu red D N A was immobilized on D B M - p a p e r 
and used to select specific and t rans la table R N A (35). T h r e e 
recombinan t p lasmids were found to re ta in R N A which di-
rec ted cell-free synthesis of prote ins which were specifically 
immunoprec ip i tab le wi th ant ibodies di rected against C3. One 
example is shown in Fig. L4, Track 6. A major t ransla t ion 
produc t migra ted a t t he s ame posit ion as pro-C3 (MT = 
175,000), bu t m a n y proteins with a lower molecular weight 
were observed. Immunoprec ip i ta t ion with ant i-C3 se rum (Fig. 
27 
mRNAs for Complement Proteins C3 and C4; cDNA Clones for C3 
200-
T 1 2 3 4 5 6 
FIG. 3. SDS-polyacrylamide electrophoresis of translation 
products of gel-eluted RNA. RNA was eluted from the gel slices 
which are indicated in Fig. 2A. The eluted mRNA was translated in 
vitro in 12.5-/d assays. Entire samples of translation products were 
analyzed by SDS-polyacrylamide gel electrophoresis. Track T, un-
fractionated mRNA (100 ng in 12.5 /il). Tracks 1 to 6, mRNA eluted 
from the Slices 1 to 6, respectively, in Fig. 1A. Molecular weight 
calibration: RNA polymerase, 165,000, 155,000; Phosphorylase a, 
98,000; bovine serum albumin, 68,000. The position of 200,000 was 
obtained by comparison of the predominant protein bands of the 
reticulocyte lysate with the calibration in Fig. 1. 
1A, Track 7) and anti-C4 serum (Fig. M, Track 8) showed 
that not only the M, = 175,000 protein but also the majority 
of the proteins of lower molecular weight were related to C3. 
The last are probably due to fragmentation of the mRNA 
during the hybridization. Again the pattern of stained proteins 
(Fig. Iß , Tracks 7 and 8) showed an efficient immunoprecip-
itation of high specificity. 
A restriction analysis with Pst I of the plasmids containing 
sequences complementary to mRNA for C3 is shown in Fig. 
4A, Tracks 1, 2, and 3. The sizes of the inserts and Pst I 
fragments of the inserts were determined using phage X DNA 
digested with Eco RI and pBR 322-DNA digested with Alu I 
as markers (data not shown). The inserts of the three C3 
plasmids measure 760 base pairs (pMLC3-2, Fig. 4A, Track 
1), 590 base pairs (pMLC3-3, Fig. 4A, Track 2), and 2900 base 
pairs (pMLC3-l, Fig. A A, Track 3). The insert of pMLC3-l 
contains three internal Pst I restriction sites, giving rise to 
fragments of the following approximate lengths: 1180, 720, 
660, and 140 base pairs (the latter one is too small to be seen 
in Fig. 4 A, Track 3). 
In order to determine whether the three clones contain 
(partially) overlapping sequences, we examined their ability 
to cross-hybridize. Pst I restriction fragments of each plasmid 
and of a control non C3-related plasmid (Fig. 4 A, Track 4) 
were separated by electrophoresis in an agarose gel and the 
DNA transferred to nitrocellulose sheets. The DNA was hy-
bridized to each of the three largest Pst I restriction fragments 
B 
2 3 
C 
FIG. 4. Restriction enzyme analysis of plasmids containing 
C3-related sequences. The DNA of recombinant plasmids pMLC3-
2 (Track /), pMLC3-3 (Track 2), pMLC3-l (Track 3), and an unre-
lated plasmid (Track 4), each 300 ng, were digested with Pst I 
restriction enzyme. Fragments were separated by electrophoresis in 
a 1% agarose gel. As size markers were used: phage A DNA digested 
with Eco RI and pBR 322 DNA digested with Alu I (data not shown). 
After staining the DNA with ethidium bromide a picture was taken 
(Panel A) and the DNA was transferred to nitrocellulose sheets and 
subsequently hybridized with nick-translated Pst I restriction frag-
ments of the insert of pMLC3-l (see text): Panel B, 1180-base pan-
fragment, Panel C, 820-base pair fragment; and Panel D, 660-base 
pair fragment. 
of the insert of pMLC3-l. These fragments were isolated by 
elution from an agarose gel and were rendered radioactive by 
nick translation. In Fig. 4, one can see that the 1180-base pair 
fragment hybridizes to the insert of pMLC3-3 and to itself 
(Fig. 4B, Tracks 2 and .3), the 820-base pair fragment hybrid-
izes to the insert of pMLC-2 and to itself (Fig. 4C, Tracks 1 
and 3), and that the 660-base pair fragment hybridized only 
to itself (Fig. 4D, Track 3). None of the fragments hybridized 
significantly with the unrelated plasmid (Fig. 4, B and D, 
Track 4). 
In order to confirm the size determination of the mRNA for 
C3 (see above), mouse liver mRNA was fractionated by elec-
trophoresis in a denaturing gel, transferred to DBM-paper, 
and hybridized with nick-translated plasmid DNA, containing 
C3 sequences (Fig. 2B, Strip 1). The hybridizing RNA species 
was determined to contain indeed approximately 7,500 bases. 
As a specificity control RNA on two other strips was hybrid-
ized with plasmid DNA which did not contain C3 sequences 
(Fig. 2B, Strips 2 and 3). 
DISCUSSION 
The cell-free translation results show that the primary 
translation products for mouse C3 and C4 proteins are large 
single chain polypeptides and that the subunits are not trans-
lated from separate, smaller mRNA species. No translation 
products of the size of mature subunits were detectable by 
immunoprecipitation. This result confirms observations of 
other authors for pro-C3 and pro-C4 molecules in other species 
(12-14) and shows that not only macrophages (15, 16) but also 
liver cells of mice produce C3 and C4 as single chain precur-
sors. Our findings confirm a preliminary report for the pres-
ence of C3 and C4 mRNA species in mouse liver (38). However 
we do not observe any proteolytic processing into fragments 
of the size of mature subunits in the cell-free system as 
described by these authors. Upon prolonged exposure of au-
toradiographs of immunoprecipitations of pro-C3 and pro-C4 
after cell-free translation, a characteristic pattern of lower 
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lolecular weight polypept ides was observed several t imes 
data not shown) . T h e same pa t t e rn was la ter observed much 
lore clearly when m R N A was t rans la ted in vitro after hybrid 
election. T h e s e proteins of lower molecular weight may rep-
esent early te rmina t ion polypeptides, due to f ragmentat ion 
f the m R N A and p rema tu re release of nascent protein from 
he polyribosomes. 
Gel eluted R N A s of the 7.5-kilobase size class (Fig. 2A, 
legion 3) and the 8.4-kilobase size class (Fig. 2A, Region 2) 
fere t rans la table into polypept ides migrat ing with the same 
nobility as pro-C3 and pro-C4, respectively. Also in this 
xper iment (Fig. 3), a background of low molecular weight 
ranslat ion products is visible, which is not likely to be due to 
on tamina t ing gel-eluted smaller rnRNAs. Therefore , prema-
ure te rmina t ion appears to be a frequent event during the 
ranslat ion of very large rnRNAs in ret iculocyte Lysates under 
t anda rd condit ions. As t he ret iculocyte lysate is incapable of 
iroperly modifying nascent polypeptides, it is unlikely t ha t 
he pro-C3 and pro-C4 molecules which we have described 
lere, are fully processed. We observed (data not shown) t ha t 
vith respect to a set of molecular weight s t anda rds the cell-
ree t rans la ted pro-C3 and pro-C4 migrate faster in gel elec-
rophoresis t h a n the intracel lular precursors from macro-
)hages, which were metabolical ly labeled. We should there-
ore designate t he cell-free t ranslat ion produc ts pre-pro-C3 
ind pre-pro-C4. However, we do not want to in t roduce this 
ïomencla ture as long as t he physical differences be tween the 
:ell-free t ransla t ion produc ts and the functional intracel lular 
>recursors a re not characterized. 
T h e finding t ha t the incompletely processed cell-free t rans-
a t ion products can be immunoprec ip i ta ted with heterologous 
intisera raised against t he se rum C3 and C4 molecules indi-
:ates t h a t the re are common antigenic de te rminan t s between 
;hese components . Th is finding was essential for t he later 
dentification of the c D N A clones. 
By in vitro t rans la t ion it is impossible to es t imate t he 
ibundancies of the rnRNAs for C3 and C4 for two reasons. 
First, we do not know how efficient the immunoprecip i ta t ion 
>f t he p roduc ts of in vitro t ranslat ion is. Second, we observed 
5y t i t ra t ing t he opt imal a m o u n t of m R N A to be used per 
;ranslation assay, t h a t t he high molecular weight R N A species 
i re t rans la ted in vitro with a lower efficiency t h a n R N A s of 
,ow molecular weight (data not shown) . 
Because none of t he recombinant plasmids hybridized sig-
nificantly (data not shown) wi th the R N A probe of low 
molecular weight (Fig. 2A, slice 7), we conclude t ha t the size 
fractionation of t he m R N A prior t o t h e molecular cloning was 
efficient. Screening of t he c D N A clones by colony hybridiza-
tion and hybr id-promoted t ransla t ion revealed three different 
plasmids containing c D N A inserts with sequence homology to 
the m R N A for C3. T h e largest insert, 2900 base pai rs (pMLC3-
1), cross-hybridizes wi th t he two smaller inserts, pMLC3-2 
and pMLC3-3 . Since no prote in sequence da t a for mouse C3 
are available for compar ison it is a t present no t easily possible 
to prove t h a t t he c D N A inserts of t h e plasmids which are 
described here are complementa ry in thei r ent i re length to 
m R N A for C3. Despi te t h e recovery of th ree independent 
clones complementa ry to port ions of m R N A for C3, a r emote 
possibility remains t h a t these plasmids carry c D N A sequences 
homologous to a C3-related bu t not identical m R N A of low 
abundancy . 
So far we have not identified any p lasmid wi th a c D N A 
insert corresponding to t he m R N A for C4. Th i s may be an 
indication t ha t the m R N A for C4 is less a b u n d a n t t h a n m R N A 
for C3. A fraction of t he cell-free t rans la ted prote ins wi th a 
molecular weight of 190,000 may not be re la ted t o C4, t h u s 
causing a wrong es t imat ion of t he abundancy of m R N A for 
C4. In th is respect, it should also be no ted t h a t t he exper iment 
in which m R N A was eluted from gel slices (Fig. 2A) showed 
t h a t R N A s eluted from the slices of the 7.5- and 8.4-kilobase 
region were bo th t ransla table into a product of MT = 190,000 
(Fig. 3). Therefore, t he re m a y be two or more m R N A species 
coding for proteins of t he same molecular weight. 
T h e final de terminat ion of t he size of the m R N A for C3 
relies on the a rgument t h a t a large majori ty of the t ranslat ion 
products of the hybrid-selected m R N A are C3-related (Fig. 1, 
Tracks 6 and 7). Therefore , the major m R N A species with 
which these cDNA plasmids hybridize on a Nor the rn blot 
should be t he m R N A for C3. Only one hybridizing species 
with a size of 7,500 bases was found (Fig. 2B, Track 1). 
For a pr imary t ransla t ion product of M, = 175,000, one 
expects a coding sequence of at most 5,300 bases. Therefore, 
t he m R N A for C3 contains at least 2,000 bases in non-
t rans la ted regions, more t h a n one-quar te r of its whole length. 
I t will be of in teres t in the future to investigate t he s t ruc tura l 
organization of t he m R N A for C3 and its gene in more detail. 
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Summary 
Synthesis of C3-protein was observed in primary mouse macrophages and in several 
t issue culture cel l l ines of mouse macrophage (J774.2 and IC21) and rat hepatic 
o r ig in (HTC and FaO) by metabolic labe l ing, immunoprecipitation and electropho-
resis in SDS-polyacrylamide gels. Af ter starch induction vn vivo of macrophages 
a decrease of C3- and C4-protein biosynthesis was observed in v i t r o , with respect 
to to ta l protein synthesis. In two ce l l l ines (HTC and J774.2) the synthesis of 
C3-protein could be decreased approximately two-fold by the addit ion of the g lu -
cocort icoid hormone dexamethasone to the medium. This decrease was observed for 
both pro-C37and mature secreted C3 and was dose dependent. The decrease occurred 
between 10 and 10 M dexamethasone. In contrast the C3-mRNA concentrations in 
J774.2 cel ls were increased approximately 1.5-fold af ter the addit ion of dexame-
thasone. 
Introduction 
An important defence mechanism against infect ions is mediated through the act iva-
t ion of the complement system in blood plasma and tissue f lu ids of vertebrates. 
Af ter th is ac t i va t ion , the clearance of foreign and own material (bacter ia, v i r u -
ses, aged cel ls e tc . ) is achieved by ce l l lys is and phagocytosis of part ic les ( for 
review see 1,2). The th i rd component of complement (C3) plays an essential role 
in both these events. In th is paper we want to report on studies on the regula-
t ion of the biosynthesis of C3. 
Hepatocytes are the major producers of C3 and of many of the other comple-
ment components. In addit ion peritoneal macrophages and a few other cel l types 
are known to synthesize C3 ( fo r review see 3,4). For the study of the C3-gene 
expression i t is advantageous to work with cultures of cel ls which express the 
* This work was performed in the Department of Molecular Biology of the Swiss 
Ins t i t u te for Experimental Cancer Research, 1066 Epalinges, Switzerland and sup-
ported by grant no. 3.273.78 of the Swiss National Science Foundation. 
* * K.G.O. was a rec ip ient of a fellowship of the Swiss Ins t i t u te for Experimental 
Cancer Research. 
31 
C3-gene and which respond f a i t h f u l l y to regulatory s t imu l i . Therefore we f i r s t 
investigated the biosynthesis of C3-protein by primary peritoneal macrophages in 
tissue culture and asked wether the mouse macrophage derived ce l l l ines IC21 (5) 
and J774.2 (6) and the rat hepatoma l ines HTC (7) and FaO (8) synthesized C3. 
Thereafter we studied the ef fect of various st imul i on the capacity of the ce l ls 
to synthesize C3-protein and in one case we compared the ef fect on the C3-protei 
synthesis with the ef fect on C3-mRNA concentrations, using a cloned cDNA hybridi 
zation probe speci f ic for C3 (9) . One of the st imul i used was the intraperitonea 
in ject ion of starch, three days before col lect ion of the peritoneal ce l l s . This 
treatment mimics a local ized inflammation and has been reported (10,11) to affec 
the synthesis of several hemolytically active complement components by guinea pi 
macrophages. Furthermore we tested the e f fec t of dexamethasone, a potent a n t i -
inflammatory agent, on the C3-synthesis in several cel l l i nes . I t has been repor 
ted (12) that hydrocortisone enhances up to nine-fold the synthesis of hemolyti-
ca l ly active C3 in a rat hepatoma l i ne . In macrophage derived ce l l l ines we want 
ed to determine, wether the C3-expression is repressed by the addit ion of dexa-
methasone, as has been reported for several macrophage secretion products,eg. 
collagenase,elastase, plasminogen act ivator (13-16), or wether i t responded in a 
d i f fe ren t way. 
Experimental procedures 
Animals and_p_rimary_cell_cultures 
DBA/2J male mice are carr ied in the breeding f a c i l i t y of our i n s t i t u t e . Primary 
cultures of peritoneal exudate cel ls from four animals per t issue culture dish 
(0 9cm) were prepared as previously described (17). In order to mimic an inflam-
mation mice were treated in t raper i toneal ly with 3 ml of 2% starch in endotoxin 
free physiological sa l t so lu t ion , three days pr ior to the col lect ion of the ce l l : 
The peritoneal cel ls from these mice are refered to as induced macrophages. Usu-
a l l y 2-3 X 10 c e l l s , containing 20-30% macrophages were obtained from control 
mice,and 20-30 X 10 ce l ls containing 60-70% macrophages from starch induced 
mi ce ' . 
Cell_l ines 
The macrophage derived cel l l ines IC21 (5) and J774.2 (6) were obtained from 
Drs. H.Engers and J.Mauel (Epalinges, Switzerland) and Dr. B.Bloom (New York, 
USA) respectively. The f i r s t are macrophages which are transformed by SV40 vi rus. 
the second derive from a natural reticulo-sarcoma. The rat hepatoma l ines HTC (7] 
and FaO (8) were obtained from Drs. K.Yamamoto (San Francisco, USA) and M.Weiss 
(Gif sur Yvette, France) respectively. In a l l experiments Dulbeccos modified 
1) Dr J.Mauel, Epalinges, Switzerland, personal communication. 
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Eagles medium supplemented with 10% heat inact ivated fe ta l bovine serum was used, 
rhe medium for the J774.2 cel ls was supplemented with 0.2 mg/ml of L-glutamine. 
[ f dexamethasone was used, the hormone was added from a 10 M solution in etha-
nol . 
Radioactive label ing and immunoprecipitation of proteins 
35 2e'\1 cultures were washed with methionine free medium and 50-120 yCi of S-meth-
ionine (10 Ci/mmole) was added in 1.5 ml of the same medium. Unless otherwise 
speci f ied, labeling was for 1.5 hrs, followed by a chase for 1.5 hrs af ter the 
addit ion of unlabeled methionine to a f i na l concentration of 300 yM. Tissue cu l -
ture supernatants were col lected, centrifuged in order to remove f loa t ing ce l ls 
and made 10 mM in N-aethylma"!?inimid. Cytoplasmic extracts were prepared as de-
scr ibed«^ sewhere (18). The proteins from 10 yl of extract were precipi tated in 
10% TCA ' and the amount of rad ioact iv i ty was determined as an estimate of the 
to ta l amount of newly synthesized protein. In some cases ( indicated in the text) 
the tissue culture supernatants were passed three times over a column with 3 ml 
of gelatin-sepharose (kind g i f t of Dr. L.Zardi, Epalinges, Switzerland), in order 
to remove f ibronect in (19). The amount of bound f ibronect in was determined af ter 
washing the column with 4 M NaCl and elut ion with 3 M urea (19). Samples were 
counted in aquasol (New England Nuclear Inc.) a f ter a 5- fo ld d i l u t i on in water. 
Ind i rect immunoprecipitation with antibodies and Staphylococcus aureus and the 
SDS-polyacrylamide gel electrophoresis were as described ear l ie r (17), except for 
the presence of 1% Na-deoxycholate and 0.1% SDS during the immunoprecipitation. 
The amount of label in individual protein bands was measured by dissolving gel 
s l ices in 0.25 ml of 30% H2O2 fo r 6-8 hrs at 80°C and counting in aquasol. Goat 
anti mouse B1C serum (anti-C3 serum) was obtained from Nordic, T i lburg , the 
Netherlands. The preparation of anti mouse C4 serum is described elsewhere (17). 
RNA technigues 
Total ce l lu la r RNA from tissue culture cel ls was prepared by extraction with hot 
phenol (20). Extraction of to ta l cytoplasmic RNA from mouse l i ve r and the iso la-
t ion of polyadenylated RNA were performed as described elsewhere (21) with minor 
modifications (9) . RNA samples were denatured in glyoxal (22) for 15 min at 50°C 
in presence of 0.2% SDS and electrophoresed through an 0.7% agarose gel in 10 mM 
Na-phosphate, pH 6.5, for 70 min at 70 mA and 10 V/cm.The RNA was transferred onto 
n i t rocel lu lose f i l t e r s (23) and hybridized to a radioactive C3 speci f ic DNA probe 
as described (9) except for the omission of the f i r s t prehybridization step. 
Results 
§lo§yG5b§§l§_2f-Ç-ipr2-e20--y ErimËry_mËÇ!T2E!]Ê9Ë§_È!]—c§Il_liDË§ 
The biosynthesis of of C3-protein by cel ls of d i f fe ren t origen was studied by 
35 
metabolic labeling of proteins with S-methionine followed by ind i rect immuno-
prec ip i ta t ion and Polyacrylamide electrophoresis of the immunoprecipitates. After 
a pulse label ing for 1.5 hrs and a chase period of 1.5 hrs in presence of an 
2) the abbreviations used are TCA, t r ich loroacet ic ac id ; SDS, sodium dodecyl su l -
phate 
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excess of unlabeled methionine, ind i rect immunoprecipitations were performed on 
cytoplasmic extracts and tissue culture supernatants, using Staphylococcus aureu 
to precip i tate immune complexes. In the experiments with primary macrophages the 
immunoprecipitates were contaminated by f ibronect in (FN in f i g . 1A) which has a 
strong a f f i n i t y for Staphylococcus aureus. A protein with a molecular weight of 
200'000 contaminated the immunoprecipitates from HTC cel ls (arrow in f i g . IB, 
track 3). 
Af ter the 1.5 hrs chase period most of the immunoprecipitable radioactive 
C3 related material was exported from the cytoplasm into the tissue culture supe 
natant for both primary macrophages and HTC ce l ls (data not shown). For routine 
purposes therefore only supernatants were examined for the presence of C3-protei 
The fol lowing molecular weights for C3 speci f ic immunoprecipitated polypeptides 
were observed: pro-C3 175'000, C3a 120'000, C3ß 75'000 (not shown) and C3X 
50'000. The last polypeptide nrobably is a breakdown product of C3ß, as we obser 
ved a reciprocal relat ionship between the abundancies of C3ß and C3X in several 
experiments (data not shown). 
The syntheses of C3-and C4-proteins by starch induced and resident primary 
mouse macrophages were compared ( f i g . 1A). In these experiments to ta l peritoneal 
exudate cel l populations were labeled, but i t is known that only the adherent 
macrophages are responsible for the synthesis of C3 and C4 protein (17). As showi 
in f i g . 1A starch induced macrophages synthesize and secrete less C4 (a,ß and y 
chains) and less C3 (achain), tracks 1 and 2 resp. , than resident macrophages, 
tracks 3 and 4. Counting of the rad ioact iv i ty contained in the individual protei i 
bands showed a 20-fold decrease for C4 and a 5-fold decrease for C3. In these 
experiments the amounts of t issue culture supernatants used for immunoprecipita-
t ion were not the same. The amounts taken were normalised in such a way that thej 
represented the same quanti ty of newly synthesized i n t race l l u la r prote in . There-
fore we compared the synthesis of C4 and C3 with the to ta l protein synthesis (see 
also the discussion). We cannot dist inguish whether the reduced synthesis of C4 
and C3 was due to a decrease in the f rac t ion of complement secreting c e l l s , or 
that a l l cel ls produced lower amounts of C3 and C4. The strong band,indicated by 
an arrow in f i g . 1A, track 3, containing polypeptides with a molecular weight of 
175'000, represents probably an intermediate processing product of pro-C4. The 
sum of a+ß chains could account for 175'000 dal ton, what would be in agreement 
with the proposed OC-S-Y order of polypeptide chains within pro-C4 (24). 
Two d i f fe rent mouse macrophage derived cel l l i nes , IC21 and J774.2 ( f i g . 1B; 
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igure 1. Biosynthesis of C3 and C4 protein by primary macrophages and of C3 pro-
te in by continuous cel l l ines 
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e l l s were metabolically labeled with S-methionine. Tissue culture supernatants 
f approximately one dish (0 9cm) were used for immunoprecipitation. Immunopreci-
i ta tes were analysed by SDS-polyacrylamide gel electrophresis. A. Indi rect immu-
oprecipitates from primary peritoneal macrophages: track 1 induced cel ls using 
nt i -C4, track 2 same using anti-C3, track 3 resident cel ls using anti-C4 and 
rack 4 same using anti-C3. B. Cell l ines : track 1 d i rect immunoprecipitate using 
nti-C3 (9) from IC21 ce l l s , track 2 ind i rec t immunoprecipitate using anti-C3 
rom J774.2 c e l l s , track 3 same from HTC cel ls and track 4 same from FaO ce l l s . 
racks 1 and 2) and two d i f fe rent rat hepatoma l i nes , HTC and FaO ( f i g . IB, 
racks 3 and 4) a l l synthesized and secreted C3-protein. Polypeptide chains with 
lolecular weights character is t ic for C3 were detected af ter immunoprecipitation: 
3a ( f i g . IB, tracks 1-4), C3X (tracks 1,2) and pro-C3 (track 1) from the t issue-
ul ture supernatants and pro-C3 from the cytoplasmic extracts (observed only 
f t e r short pulse label ings; for J774.2 see f i g . 2, track 2, for the others the 
ata are not shown). The polypeptide of 200'000 dal ton, indicated by an arrow in 
i g . IB, track 3, is probably not related to C3, as i t st icks to Staphylococcus 
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jreus even in the absence of antibodies. Using the supernatant from the FaO l ine 
f i g . IB, track 4 ) , a series of small polypeptides was immunoprecipitated, the 
" ig in of which was not investigated any fur ther . The samples used for the immuno-
recip i tat ions shown in f i g . IB, tracks 2, 3 and 4, were depleted from fibronec-
in before the immunoprecipitation (see experimental procedures). In t issue cu l -
j re supernatants of HTC cel ls ( f i g . IB, track 3) f ibronect in represented 300-
Dld more radioactive protein than C3, whereas the FaO and J774.2 cel ls only pro-
need neglegible amounts of f ib ronect in . The IC21 cel ls were not tested for the 
resence of f ibronect in and the immunoprecipitation shown in f i g . IB, track 1 , 
as obtained in an independant experiment by d i rect immunoprecipitation (9 ) . 
f fec t of_dexamethasone on the synthesis of C3-p_rotein 
he ef fect of the synthetic glucocort icoid hormone dexamethasone on the biosyn-
hesis of C3-protein was tested on HTC, FaO and J774.2 ce l l s . Dense cultures were 
aintained in the absence or the presence of 10 M dexamethasone for 24-48 hrs 
r i o r to and during metabolic label ing. The synthesis of C3-protein was detected 
s described above and the amounts of rad ioact iv i ty contained in the C3 band 
f t e r immunoprecipitation and gel electrophoresis were measured (table 1). For 
he HTC cel ls the amount of newly synthesized f ibronect in also was determined 
see experimental procedures). From table 1 i t is clear that the amount of newly 
ynthesized C3 is reduced by approximately two-fold in presence of 10 M dexa-
ethasone in the HTC and J774.2 c e l l s , whereas in the FaO cel ls only a minor de-
rease was observed. In contrast the amount of f ibronect in synthesized by HTC 
e l l s increased two to three-fo ld a f ter addition of 10"6M dexamethasone. The syn-
hesis of C3 by J774.2 cel ls in respons to d i f fe rent hormone concentrations was 
lso followed ( f i g . 2 , tracks 3-8). Dense cultures were maintained for 48 hrs af ter 
ddi t ion of increasing amounts of dexamethasone and subsequently labeled. One 
ul ture was incubated with 10 M dexamethasone for 24 hrs (long enough to cause 
two-fold decrease of the C3 synthesis), followed by another 24 hrs without hor-
lone ( f i g . 2, track 9) . Furthermore the ef fect of 10 M dexamethasone on the syn-
desis of i n t race l lu la r pro-C3 was tested by pulse labeling cel ls for 30 min f o l -
owed by immunoprecipitation from the cytoplasmic extract ( f i g . 2, tracks 1 and 2) 
he quantative evaluation of the experiment is shown in table 2. The results show 
;hat the newly synthesized i n t race l l u la r pro-C3 and ext race l lu lar mature C3 are 
loth reduced approximately two-fold by 10 M dexamethasone compared to control 
iultures (no hormone). The reduction occurs in the concentration range between 
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Figure 2. Response of the C3-protein biosynthesis to dexamethasone in J774.2 cel ' 
J774.2 cel ls were incubated for 48 hrs in the presence of increasing amounts of 
dexamethasone and subsequently metabolically labeled with S-methionine. I n -
d i rect immunoprecipitations using anti-C3 were performed from tota l cytoplasmic 
extracts (tracks 1 and 2) and from to ta l t issue cul ture supernatants (tracks 3-i 
One culture dish (0 6cm) was used per point . The molar concentrations of dexa-
methasone are indicated above the tracks. The cel ls used for track 9 were f i r s t 
incubated for 24 hrs in presence of hormone and thereafter for 24 hrs without 
hormone. 
-8 -7 
10 and 10 M dexamethasone ( f i g . 2 , tracks 6 and 7). The ef fec t of the hormon* 
is at least p a r t i a l l y reversible because withdrawal of the hormone and a 24 hrs 
recovery period an increase in the synthesis of C3 was observed ( f i g . 2, track ! 
The observation that 10" M dexamethasone has the same ef fect on the syn-
thesis of pro-C3 and the appearance of mature C3-protein in the tissue culture 
supernatant indicates that the hormone probably does not act on the level of 
post- t ranslat ional processing and secret ion, but rather on the level of trans-
l a t i o n , mRNA synthesis or mRNA degradation. 
Tlt!:ation_of_C3;mRNA 
In order to determine wether the dexamethasone dependent decrease of the C3-pro-
tein reflects different abundancies of the C3-mRNA in hormone treated and contre 
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UBLE 2 . RESPONSE OF THE C3-PROTEIN BIOSYNTHESIS TO DEXAMETHASONE 
examethasone 
oncentration 
M 
pm/band . 
10-3 a) 
of control 
pro-C3 
10'6 0 
5.8 11.8 
49 100 
C3u 
0 
12.0 
100 
ID"10 
13.9 
116 
10"9 
12.2 
102 
lO-8 
14.8 
123 
ID"7 
5.8 
48 
10"6 
4.8 
40 
10"6/0 
7.4 
62 
Pro-C3 and C3a bands were excised from the gel in f i g . 2, solubi l ized and 
ounted. The values are corrected for differences in the incorporation of 
ethionine into to ta l newly synthesized proteins. 
:e l l s , the C3-mRNA concentrations in these cel ls were compared. 
Total mRNA (9 yg) , prepared from J774.2 cel ls maintained for 48 hrs in 
0 M dexamethasone ( f i g . 3A, tracks 2 and 4) and from control cel ls ( f i g . 3A, 
racks 1 and 3) was size fract ionated by electrophoresis in agarose gels. As 
hown by staining the RNA with ethidium bromide ( f i g . 3A, tracks 1 and 2) the 
'Verall mRNA patterns from hormone treated and control cel ls were not s i g n i f i -
:antly d i f fe ren t . The re la t ive amounts of C3-mRNA were determined by transfer of 
;he RNA from the gel onto a n i t roce l lu lose f i l t e r and subsequent hybridizat ion 
o an excess (300 ng) of a radioactive cloned cDNA probe, specif ic for C3-mRNA 
9) . The autoradiograph in f i g . 3A shows that the C3-mRNA is more abundant in 
he sample from hormone treated cel ls (track 3) than from control cel ls (track 3). 
he amount of hybridized cDNA in both bands was determined by s c i n t i l l a t i o n 
ounting and showed a difference of 1.7- fo ld. The r e l i a b i l i t y of th is measure-
îent is demonstrated in f i g . 3A, tracks 5-7, where decreasing amounts of to ta l 
iRNA from mouse l i v e r were loaded in each track. The amount of hybridized C3-cDNA 
»as precisely proportional to the amount of l i ve r mRNA ( f i g . 3B). In three inde-
iendent mRNA preparations, the abundancies of the C3-mRNA were determined to be 
.5 ± 0.2 fo ld higher for dexamethasone treated cel ls than for control ce l l s , 
hus there is an opposite e f fec t of the hormone on the steady state level of the 
3-mRNA and on C3-protein synthesis. 
Kb 
9.3-
6.4-
5.1-
4 3 -
1600 
1200 
II 
0.35 0.88 2.1 
/ug liver mRNA 
Figure 3. T i t ra t ion of C3-mRNA 
A. mRNA samples were denatured in glyoxal 
through an 0.72 agarose ge l . The RNA was 
and 2, or transferred onto n i t rocel lu lose 
cDNA probe for C3-mRNA (9 ) , tracks 3-7. T 
ce l l s . Tracks 2 and 4: 9 yg of mRNA from 
10~6 M dexamethasone. Tracks 5-7 decreasi 
0.88 yg and 0.35 yg respectively. E.coli 
samples 6 and 7. B. Determination of the 
C3-bands were excised and counted in sein 
and fract ionated by electrophoresis 
stained with ethidium bromide, tracks 1 
and hybridized to a radioactive clonec 
racks 1 and 3: 9 yg of mRNA from J774.2 
J774.2 cel ls treated for 48 hrs with 
ng amounts of mouse l i ve r mRNA: 2.1 yg, 
tRNA (1 yg) was added as car r ie r to 
amount of hybridized cDNA in tracks 5-7 
f i l i a t i o n l i qu i d . 
Discussion 
Metabolic labeling of proteins for a short time followed by immunoprecipitation 
and determination of the amount of rad ioact iv i ty in specif ic protein bands, pro-
vides a re l iable method to quantify re la t ive rates of biosynthesis of speci f ic 
proteins. Because the poolsize and speci f ic ac t i v i t y of the radioactive precursc 
might vary inside the ce l ls in d i f fe rent ce l l cu l tures, the resul ts have to be 
normalized with respect to the tota l amount of rad ioact iv i ty incorporated in 
newly synthesized protein. 
Macrophages. Resident mouse peritoneal macrophages were compared with stare 
induced peritoneal macrophages for the rates of biosynthesis of C3 and C4-protei 
The resident ce l ls synthesized substant ia l ly (5 and 20-fold) more C3 and C4 than 
induced ce l l s . For C3 no s imi lar observations have been published but for the 
guinea pig C4 opposite results have been reported (11). In that report the b io-
synthesis of C4-hemolytic ac t i v i t y was shown to increase upon starch induct ion, 
while the f rac t ion of C4 producing cel ls remained constant and no s ign i f i cant 
change in the C4-protein (radioactive antigen) synthesis was detected. I t is d i f 
40 
i c u l t to compare the results on the radioactive labeling in th is report (11) 
i t h ours, because the authors normalised the i r data with respect to the number 
f ce l ls or the amount of rad ioac t iv i ty incorporated in secreted proteins. In our 
ands the secreted proteins represented only 5', of the newly synthesized protein 
data not shown) and therefore we normalized with respect to the rad ioact iv i ty 
ncorporated into the proteins in the cytoplasmic extract . An inherent difference 
etween mice and guinea pigs could also explain these divergent resul ts . 
Cell l ines . We demonstrated the biosynthesis of C3-protein in tissue culture 
e l l l ines of both hepatic and macrophage o r i g i n . Previously i t has been repor-
ed (12) that several rat hepatoma lines produced and secreted C3-act iv i ty . We 
ave tested the subline FaO (8) of the ce l l l ine H4 (12) and confirmed the ear-
ie r observation on the protein level by metabolic labeling and immunoprecipita-
ion. In addit ion we found that also the HTC l ine (7) synthesized C3-protein a l -
though at a much lower leve l . For macrophage derived cel l l ines no clearcut ev i -
dence of C3 synthesis has been reported. We found the IC21 (5) and J774.2 (6) 
ines to be strong producers of C3-protein. Although the IC21 ce l ls synthesized 
lore C3-protein, the J774.2 cel ls were chosen for fur ther investigations because 
If the i r shorter generation time. 
The IC21 and J774.2 l ines were also tested for the biosynthesis of C4-pro-
;ein. The J774.2 l ine did not produce detectable amounts of C4 and with the IC21 
ine we obtained only weak indicat ion for the synthesis of some C4 related mate-
•ial (data not shown). I t is interest ing that both these cel l l ines produce much 
lore C3-protein than C4-protein whereas for primary macrophages we found about a 
Five fo ld higher synthesis of C4 than of C3, especially because the or ig in of 
these cel l l ines is very d i f fe ren t . The IC21 l ine was obtained by transformation 
3f macrophages with SV40 virus and the J774.2 l ine generated from a natural tumor 
)f the re t i cu loendo the l ia l sytem (reticulo-sarcoma). 
Some of the experiments with cel l l ines and primary macrophages have also 
jeen performed using a d i rect immunoprecipitation method (9) . Because cold com-
plement proteins from plasma were co-precipitated with the radioact ively labeled 
proteins in those experiments, i t was possible to compare d i rec t l y the sizes of 
the subunits of the components in plasma with the ones syntheszed in tissue cu l -
ture. Whereas for C3 no differences were observed, the C4« chain from macrophage 
"A, synthesized in v i t r o , was measured to be approximately 5000 daltons larger 
than the C4« chain in plasma. Similar observations have been reported ear l ie r (25). 
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Effect of dexamethasone. Dexamethasone, a synthetic glucocort icoid hormone, 
is a potent anti-inflammatory agent. For both l i ve r cel ls and macrophages i t has 
been reported that the secretion of several proteins is affected by g lucocort i -
coids (13-16,26), eg. elastase, collagenase and plasminogen act ivator . C3 synthe 
sis as measured by by hemolytic a c t i v i t y , has been reported to increase up to 
n ine-fo ld upon addition of hydrocortisone to the medium of the rat hepatoma cel l 
l ine H4 (12). We tested a subline (FaO) of the H4 l ine for i t s response to dexa-
methasone, but no s ign i f i cant ef fect was observed. Poss ib i l i t ies to explain this 
difference are a) the subline has los t i t s glucocort icoid response, b) a d i f f e r -
ent glucocort icoid hormone was used, c) hemolytically active C3 is not proportie 
nal to radioactive antigen. The rat hepatoma l ine HTC however, showed a two-fold 
decrease in the C3-protein synthesis. Because in the same experiments we observe 
a two-fold increase in the synthesis of f ibronect in upon addit ion of dexametha-
sone, the decrease in C3-protein synthesis is not simply due to a toxic ef fect o 
dexamethasone. Also for primary hepatocytes i t has been shown that the amount of 
f ibronect in can be increased by incubation in presence of dexamethasone (27). 
Fibronectin was iden t i f i ed by i t s molecular weight, a f f i n i t y for Staphylococcus 
aureus and gelatin-sepharose (16) and in independent experiments by immunopre-
c ip i t a t i on (14). 
The macrophage l ine J774.2 also responded to dexamethasone with a two-fold 
decrease of C3-protein synthesis. Because these cel ls produce much more C3 than 
the HTC c e l l s , fur ther characterisation of the dexamethasone response was per-
formed on J774.2 ce l l s . The decrease in the C3-protein synthesis occured between 
O _ "7 
10 and 10 M dexamethasone. This is very similar to results obtained for the 
secretion by macrophages of proteases such as collagenase and elastase (14). The 
concentration of glucocorticoids in our fetal bovine serum was measured to be 
below 10 M (data not shown) and therefore their contribution can be neglected 
In most of the studied cases where steroid hormones influence the expressio 
of genes (i.e. egg-white and egg-yolk proteins with estrogens), the change in 
the steady state concentrations of the mRNAs can account for the effect observed 
on the protein synthesis. We have tested wether this is also true for the C3-
mRNA concentrations in J774.2 cells in presence and absence of dexamethasone. 
Although reproducibly a two-fold decrease was found for the C3-protein synthesis 
the mRNA concentration for C3 was reproducibly 1.5-fold higher in the presence 
of dexamethasone. This means that dexamethasone must have multiple effects on 
these cells, affecting in opposite ways the transcription and translation. Stu-
42 
lies on the expression of proteins and mRNA of mouse mammary tumor virus (MMTV) 
lenes in MMTV infected HTC cel ls (28) and in L cel ls transfected with MMTV-DNA 
18) demonstrated a large increase in the concentration of virus specif ic RNA 
ipon the addit ion of dexamethasone to the culture medium, but only a several 
rold lower increase in the synthesis of v i ra l proteins. The lower ef f ic iency of 
:ranslation of speci f ic mRNAs could be due to an influence of the hormone on the 
;ranslational apparatus or to an accumulation of aberrant (untranslatable) mRNAs. 
rhese poss ib i l i t i es could be tested by i_n v i t ro t ranslat ion studies. 
The size determination of C3-mRNA in f i g . 3A, using glyoxylated mRNA, d i f -
fers substant ia l ly from the value we reported previously. There methyl-mercury-
lydroxide was used for the denaturation of the mRNA and a value of 7500 nucleo-
tides was determined (9) in stead of 5300. Further experiments have to be per-
formed in order to establ ish what the correct value i s . 
The method used for the comparison of C3-mRNA concentrations ( f i g . 3 ) , pro-
vides an addit ional tool for the detection of the expression of the C3-gene and 
for comparative studies on the effects of regulatory s t i m u l i , such as a n t i - i n -
flammatory agents, on the expression of the C3-gene. 
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j CONCLUDING REMARKS 
The mayor part of the work reported in this thesis, aimed at the generation 
ind isolation of DNA probes complementary to the messenger RNA for the complement 
:omponents C3 and C4. Indeed for the complement component C3 the isolation of a 
:omplementary DNA probe has been successful and therefore it has become possible 
:o perform detailed studies on the gene(s) and the RNA transcripts for this 
:omponent. 
Recent results (unpublished ) revealed that among the clones harboring recom-
n'nant plasmids (310, see chapter 3) eleven (3%) contained C3-specific sequences, 
line of these contained different plasmids with partially overlapping C3-cDNA 
inserts, covering in total 4700 nucleotides (90%) of the C3-mRNA. 
The C3-cDNA probes are now used for a variety of experiments in different 
lines of investigation, a) Further characterization of C3-mRNA. In chapter 3 the 
:3-mRNA was estimated to contain 7500 nucleotides. This value was obtained by 
electrophoresis of mRNA in presence of the denaturing agent methyl mercury hydro-
xide. In chapter 4, using glyoxal for the denaturation of the RNA, C3-mRNA was 
found to contain only 5300 nucleotides, several independent experiments i.e. 
primer extended reverse transcription and digestion of C3-mRNA with RNase H after 
hybridization to C3-cDNA fragments, indicate that the value of 5300 probably is 
correct. Also the length of the mRNA for vitellogenin, which has a similar size 
as C3-mRNA, has been overestimated, using the methyl mercury hydroxide method 
(Dr. G. Ryffel, personal communication), b) Gene expression. Several aspects of 
the regulation of the expression of the gene for the complement component C3 have 
been studied in chapter 4. Sofar no convenient model system for the modulation 
of the expression of the C3-gene has been found, in which it will be possible to 
study the mechanism of control of gene expression. The continuous presence of 
complement component C3 might be so essential that its gene is expressed consti-
tutively in the producer tissues and that major regulation never takes place. 
In any case, if in future regulatory stimuli will be found which have a strong 
effect on the expression of the C3-gene, tools for a detailed study of the mecha-
nism are available, c) Gene structure. The mouse and human C3-genes have been 
analysed by digestion with several restriction enzymes, followed by size fracti-
1) All the unpublished results which are mentioned in this chapter were obtained 
in a collaboration of the following persons (in alphabetical order) : 
Horst Domdey, George Fey, Verena Müller, Karel Odink and Karin Wiebauer. 
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onation and detection of the C3-specific fragments by hybridization to radio-
actively labeled C3-cDNA. Fragments of the C3-gene, comprising at least 90% of 
the sequences coding for C3-mRNA, have been isolated from a mouse gene library. 
Results from several experiments are to be expected soon : the determination of 
the number of C3-genes in the mouse and human genome; the location of the human 
gene(s) on a chromosome(s), with the use of human-mouse hybrids cells; sequence 
analysis of parts of the C3-cDNA, which will possibly reveal the amino acid se-
quence of the C3a polypeptide and of the portion of C3b which contains the bindi 
site for cells and particles (see 1.3.4 and 1.3.5). 
All these examples show that a new approach has become available to answer 
questions about the expression, genetic aspects and structural aspects of the 
gene for the complement component C3. 
For the complement component C4 the isolation of a complementary DNA probe 
has not been successful so far. The serum level of C4-protein is approximately 
three fold lower than for C3-protein. This might reflect a lower abundancy of thi 
C4-mRNA in the liver. Indeed, after in vitro translation of liver mRNA and immuni 
precipitations using anti-C3 and anti-C4 sera, much less (at least ten fold) pro-
C4 was found than pro-C3 (chapter 3). But low efficiency of the immunoprecipita-
tion with anti-C4 could also explain these results. However, if macrophage mRNA 
is used for in vitro translation, the immunoprecipitations with anti-C4 and anti-
C3 are equally efficient. Therefore it is likely that part of the polypeptides, 
obtained after in vitro translation of liver mRNA, which have a molecular weight 
of 190'000 is not related to pro-C4 and that indeed C4-mRNA appears approximately 
ten fold less abundant than C3-mRNA in liver. This in turn could explain why no 
recombinant plasmids were found which contained cDNA inserts for C4-mRNA. A 
larger collection of clones containing recombinant plasmids should be made in 
order to increase the chance of isolating a C4-cDNA probe. A C4-DNA probe would 
provide an entrance into the major histocompatibility complex and could help 
to elucidate whether there is a relation between this complex and the complement 
system, other than the location of some of the complement genes within the 
major histocompatibility complex. 
It is conceivable that in the future, apart from the complement components 
C3 (and C4?), for the other components of the complement system cDNA clones will bi 
isolated. However, serious problems might be encountered due to low abundancies 
of their mRNA. If these isolations will be succesfull, the coherance in the regu-
lation of the biosynthesis of the complement components might become understood. 
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B SAMENVATTING 
Het complement systeem vormt een belangri jk verdedigingsmechanisme tegen infec-
t ies in de mens en andere vertebraten. B i j de act iver ing van d i t systeem, die 
door antigeen-antilichaam-complexen en verder door een groot aantal andere sub-
stanties geïnduceerd kan worden, z i j n ten minste zestien serumeiwitten betrokken. 
De act iver ing van het complement systeem verlooot via een waterval-achtige reeks 
van e iwi tsp l i ts ingen en de vorming van eiwitcomplexen. Het u i te inde l i j ke resul-
taat is dat de infectieuze substantie snel u i t het organisme wordt verwijderd. 
Het is onduidel i jk hoe de controle van de expressie van de genen van het 
complement systeem verloopt en hoe wordt geregeld dat de j u i s te hoeveelheden 
verschillende complement e iwi t ten worden gesynthetiseerd. Een onderzoek naar de 
structuur van de betrokken genen en een analyse van de overschri jv ing van deze 
genen in boodschapper-RNA kan t o t de verheldering van deze problemen bi jdragen. 
Verder kunnen deze studies bijdragen to t het begrip van genetisch bepaalde gebre-
ken in componenten van het complement systeem. 
De ontwikkeling van de zogenaamde recombinant DNA technieken heeft het on-
langs mogelijk gemaakt deze problemen aan te pakken. Boodschapper-RNA kan als 
matr i js worden gebruikt voor de kunstmatige synthese van complementair-DNA (cDNA). 
Dubbelstrengs cDNA kan in het DNA van een bacterieel plasmide worden ingevoegd. 
Het op die wijze gemaakte "recombinant" DNA kan worden gebruikt om bacteriën te 
transformeren, waarna grote hoeveelheden schoon cDNA u i t rein-cul turen (cloons) 
van deze bacteriën kunnen worden geïsoleerd. Aangezien d i t DNA complementair is 
aan een boodschapper-RNA en aan het bijbehorende gen, kan het worden gebruikt 
om d i t RNA en het gen te herkennen en wordt het daarom "DNA-probe" genoemd. 
Het voornaamste doel van het hier beschreven onderzoek was een DNA-probe 
te isoleren voor de derde en vierde component van het complement systeem. 
In hoofdstuk 1 wordt beschreven welke strategie is gevolgd om deze DNA-
probes te isoleren. Verder wordt het mechanisme van het complement systeem in het 
kort uiteen gezet en wordt de huidige kennis van de biosynthese van de componen-
ten samengevat. 
Hoofdstuk 2 handelt over de gedeeltel i jke zuivering van component C4 u i t 
muizeplasma en over de bereiding van een monospecifiek antiserum tegen muize-C4. 
Antisera z i j n van essentieel belang voor de i d e n t i f i c a t i e van eiwi t ten en daar-
door voor de i d e n t i f i c a t i e van boodschapper-RNA door verta l ing in een c e l - v r i j 
eiwitsynthetiserend systeem. Voor C3 z i j n antisera in de handel verkr i jgbaar. 
In hoofdstuk 3 wordt beschreven hoe de C3- en C4-boodschapper-RNA's door 
47 
verta l ing in v i t ro z i j n gekarakteriseerd en hoe deze RNA's gedeel te l i jk z i j n 
gezuiverd. Verder wordt beschreven hoe een RNA-preparaat, dat v e r r i j k t was in 
C3- en C4-RNA, is gebruikt in de bovengenoemde cloningsprocedure en hoe drie 
bacterie-cloons die C3-cDNA bevatten z i j n geïsoleerd. 
Hoofdstuk 4 handelt over de bestudering van enige aspecten van de biosynthes 
van C3-eiwit door primaire muizemacrophagen en door diverse typen cellen in weef 
selkweek. De C3-cDNA-probe is daarbi j gebruikt om C3-boodschanper-RNA concentra-
t ies te vergel i jken met de mate van C3-eiwitsynthese. Het ef fekt van het hormoon 
dexamethason, dat als krachtig anti-ontstekingsmiddel toepassing v indt , is be-
studeerd. Merkwaardig genoeg is daarbi j gebleken dat d i t hormoon een tegengestel 
ef fekt heeft op de concentratie van het C3-boodschapner-RNA en de C3-eiwitsynthe' 
se in cellen in weefselkweek. De eerste bleek toe te nemen te rw i j l de tweede af-
nam. 
In hoofdstuk 5 wordt een nabeschouwing gegeven over wat mogelijk is gewordei 
nu C3-cDNA beschikbaar i s . Verder wordt ingegaan op de vraag waarom het nog niet 
is gelukt een C4-cDNA te isoleren en hoe wel l i ch t in de toekomst meer succes kan 
worden geboekt. 
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